{
  "analysis_id": "6a702566-6c18-4f35-bf53-fe499a94a74e",
  "scenario_id": "vaccines_cached_gpt_5_2_8f9bbdf5",
  "proposition": "Do vaccines cause autism in children?",
  "report": "# BFIH Analysis Report: Do vaccines cause autism in children?\n\n**Analysis conducted using Bayesian Framework for Intellectual Honesty (BFIH)**\n\n---\n\n## Executive Summary\n\n**Verdict:** REJECTED based on posteriors\n\nOur analysis under the privileged K0 paradigm finds that the hypothesis H2 (\u201cNo causal link exists\u201d) carries an overwhelming posterior probability of 0.7267. In contrast, the direct\u2010causation hypothesis H1 (\u201cVaccines directly cause autism\u201d) has a vanishingly small posterior of 0.0010. The remaining hypotheses (H3\u2013H5) share modest posterior support (0.0617\u20130.0972), while the catch\u2010all H0 sits at 0.0194.\n\nUnder K0, H2 clearly dominates, reflecting strong epidemiological evidence. Across the skeptical (K1) and precautionary (K2) paradigms, however, the most supported hypothesis shifts to H3 (\u201cRare subgroup vulnerability\u201d), with posteriors of 0.3104 and 0.3120 respectively. This divergence highlights paradigm dependence in the partial\u2010effect interpretations but does not challenge the robust rejection of widespread causation.\n\nKey evidence driving these conclusions includes large-scale cohort and case-control studies showing no increased autism risk post\u2010vaccination, meta-analyses totaling millions of children, and mechanistic investigations that find no credible neurotoxic pathway for vaccine components. The infamous Wakefield study has been discredited for methodological flaws and conflicts of interest, further diminishing any signal for causation.\n\nWhile the rejection of a general causal link (H2) is robust under the scientific\u2010consensus paradigm, alternative paradigms assign nontrivial weight to rare or indirect effects (H3\u2013H5). Stakeholders emphasizing precaution or distrust of institutions should thus note residual uncertainty for small vulnerable subgroups, even as the broad epidemiological conclusion remains firm.\n\n---\n\n## 1. Paradigms Analyzed\n\n### K0: Scientific Consensus\n\nMainstream scientific and medical consensus based on epidemiological evidence, meta-analyses, and mechanistic biology.\n\n*(No explicit stance data available)*\n\nUnder this paradigm, national and international health bodies rely on high\u2010quality trials and surveillance data to assess vaccine safety.\n\n### K1: Vaccine Skeptic\n\nPerspective that questions vaccine safety claims, emphasizes anecdotal reports, and distrusts pharmaceutical/regulatory institutions.\n\n*(No explicit stance data available)*\n\nProponents often highlight case anecdotes and alleged regulatory capture to argue for unrecognized risks.\n\n### K2: Precautionary\n\nAccepts most vaccine science but emphasizes unknown long-term risks and subgroup vulnerabilities.\n\n*(No explicit stance data available)*\n\nThis view acknowledges the general safety profile but calls for ongoing monitoring and targeted research on sensitive cohorts.\n\n---\n\n## 2. Hypothesis Set\n\n**H0: OTHER \u2013 Unforeseen explanation**  \nThis hypothesis posits that neither vaccines nor known confounders explain the observed autism incidence. Some unknown factor\u2014genetic, environmental, or methodological\u2014accounts for the apparent temporal association. It captures residual uncertainty beyond the other defined scenarios.\n\n**Prior Probabilities:**\n\n| Paradigm | Prior P(H0) | Rationale                                  |\n|----------|-------------|--------------------------------------------|\n| K0 (Scientific Consensus)       | 0.05        | A small chance of unknown confounders      |\n| K1 (Vaccine Skeptic)       | 0.10        | Skeptics allow broader unknowns            |\n| K2 (Precautionary)       | 0.10        | Precautionary stance keeps room for unknown|\n\n---\n\n**H1: TRUE \u2013 Vaccines directly cause autism**  \nVaccines or their components (e.g., thimerosal, aluminum) exert neurotoxic or immune\u2010mediated effects that trigger autism. Mechanisms might include disruption of the blood\u2013brain barrier, chronic inflammation, or gut\u2010brain axis perturbation. This is the classical vaccine-autism claim.\n\n**Prior Probabilities:**\n\n| Paradigm | Prior P(H1) | Rationale                                          |\n|----------|-------------|----------------------------------------------------|\n| K0 (Scientific Consensus)       | 0.05        | Scientific consensus deems this highly unlikely    |\n| K1 (Vaccine Skeptic)       | 0.35        | Skeptics assign significant weight to anecdotes     |\n| K2 (Precautionary)       | 0.10        | Precautionary allows minimal prior but remains open|\n\n---\n\n**H2: FALSE \u2013 No causal link exists**  \nVaccination timing coincides with the age when autism is typically diagnosed; there is no causal relationship. Large epidemiological studies, registry analyses, and meta-analyses have consistently found no increased risk of autism following vaccination.\n\n**Prior Probabilities:**\n\n| Paradigm | Prior P(H2) | Rationale                                              |\n|----------|-------------|--------------------------------------------------------|\n| K0 (Scientific Consensus)       | 0.60        | Consensus based on overwhelming epidemiological data   |\n| K1 (Vaccine Skeptic)       | 0.10        | Skeptics give it low prior due to institutional distrust|\n| K2 (Precautionary)       | 0.30        | Precautionary trusts data but remains cautious         |\n\n---\n\n**H3: PARTIAL \u2013 Rare subgroup vulnerability**  \nA small genetically or immunologically susceptible subgroup may experience neurodevelopmental harm from vaccines. This subgroup\u2019s size is too small to be detected in broad population studies, but case series and family clustering suggest its existence.\n\n**Prior Probabilities:**\n\n| Paradigm | Prior P(H3) | Rationale                                                    |\n|----------|-------------|----------------------------------------------------------------|\n| K0 (Scientific Consensus)       | 0.10        | Scientific consensus allows limited residual subgroup risk   |\n| K1 (Vaccine Skeptic)       | 0.20        | Skeptics see subgroup effects as a key to reconcile anecdotes |\n| K2 (Precautionary)       | 0.20        | Precautionary prioritizes investigation of vulnerable children|\n\n---\n\n**H4: PARTIAL \u2013 Indirect pathway via immune activation**  \nWhile vaccines do not directly cause autism, the immune response they provoke may interact with pre-existing conditions (e.g., mitochondrial dysfunction) to affect neurodevelopment indirectly. The effect is context-dependent and mediated by cytokine cascades or microglial activation.\n\n**Prior Probabilities:**\n\n| Paradigm | Prior P(H4) | Rationale                                                        |\n|----------|-------------|------------------------------------------------------------------|\n| K0 (Scientific Consensus)       | 0.10        | Consensus: indirect mechanisms remain speculative                |\n| K1 (Vaccine Skeptic)       | 0.15        | Skeptics emphasize possible immune\u2010mediated links                |\n| K2 (Precautionary)       | 0.15        | Precautionary sees plausible but unproven immunological effects  |\n\n---\n\n**H5: PARTIAL \u2013 Timing/schedule effects only**  \nThe standard vaccination schedule, with multiple antigens administered in a short interval, might transiently overwhelm an immature immune system in a subset of children. The cumulative effect could contribute to developmental perturbations without a single vaccine being the culprit.\n\n**Prior Probabilities:**\n\n| Paradigm | Prior P(H5) | Rationale                                                       |\n|----------|-------------|-----------------------------------------------------------------|\n| K0 (Scientific Consensus)       | 0.10        | Consensus views schedule overload theory as unsubstantiated     |\n| K1 (Vaccine Skeptic)       | 0.10        | Skeptics point to schedule as a compromise explanation          |\n| K2 (Precautionary)       | 0.15        | Precautionary highlights schedule timing as an area for review  |\n\n---\n\n## 3. Evidence Clusters\n\n### Cluster: C1\n\n**Description:** Large cohort/case-control studies and meta-analyses examining MMR, thimerosal/ethylmercury, antigen load, prenatal influenza vaccination, and temporal/timing variables; overwhelmingly report no association with ASD.  \n**Evidence Items:** E1, E3, E4, E6, E9, E10, E14, E17, E18, E19, E20, E24, E26, E27, E28, E29, E30, E31, E32, E37, E41, E43, E44, E45, E46\n\n| Hypothesis | P(E\\|H) | P(E\\|\u00acH) | LR | WoE (dB) | Direction |\n|------------|--------|---------|-----|----------|-----------|\n| H0 (OTHER - Unforeseen explanation) | 0.49 | 0.7274 | 0.6737 | -1.72 | Weak Refutation |\n| H1 (TRUE - Vaccines directly ca...) | 0.12 | 0.7468 | 0.1607 | -7.94 | Moderate Refutation |\n| H2 (FALSE - No causal link exists) | 0.85 | 0.5138 | 1.6545 | 2.19 | Weak Support |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.62 | 0.7261 | 0.8539 | -0.69 | Weak Refutation |\n| H4 (PARTIAL - Indirect pathway ...) | 0.58 | 0.7306 | 0.7939 | -1.0 | Weak Refutation |\n| H5 (PARTIAL - Timing/schedule e...) | 0.55 | 0.7339 | 0.7494 | -1.25 | Weak Refutation |\n\nIn this large\u2010scale cluster, the LR for H1 (0.1607, WoE \u20137.94 dB) indicates moderate refutation of a direct vaccine\u2013autism link, while most other causal hypotheses (H3\u2013H5) are weakly refuted (LR < 1, small negative WoE). Only H2 shows weak support (LR = 1.6545, WoE = 2.19 dB), suggesting that nonspecific immune\u2010mediated mechanisms might merit further study, but this signal is much smaller than the refutation of direct causation.\n\n### Cluster: C2\n\n**Description:** Consensus statements and major reviews (IOM/NASEM, CDC, AAP, WHO, Brookings expert commentary, and similar) concluding no link between vaccines (including MMR, thimerosal/aluminum) and autism, and/or no schedule-timing link.  \n**Evidence Items:** E2, E8, E11, E12, E13, E21, E25, E33, E34, E36, E42, E49, E50\n\n| Hypothesis | P(E\\|H) | P(E\\|\u00acH) | LR | WoE (dB) | Direction |\n|------------|--------|---------|-----|----------|-----------|\n| H0 (OTHER - Unforeseen explanation) | 0.58 | 0.7358 | 0.7883 | -1.03 | Weak Refutation |\n| H1 (TRUE - Vaccines directly ca...) | 0.18 | 0.7568 | 0.2378 | -6.24 | Moderate Refutation |\n| H2 (FALSE - No causal link exists) | 0.9 | 0.47 | 1.9149 | 2.82 | Weak Support |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.52 | 0.7511 | 0.6923 | -1.6 | Weak Refutation |\n| H4 (PARTIAL - Indirect pathway ...) | 0.5 | 0.7533 | 0.6637 | -1.78 | Weak Refutation |\n| H5 (PARTIAL - Timing/schedule e...) | 0.48 | 0.7556 | 0.6353 | -1.97 | Weak Refutation |\n\nMajor expert reviews strongly refute a direct causal link (H1: LR = 0.2378, WoE = \u20136.24 dB) and weakly refute other vaccine\u2010specific mechanisms (H3\u2013H5). The only hypothesis with LR > 1 is H2 (LR = 1.9149, WoE = 2.82 dB), reflecting modest support for general immune\u2010mediated pathways but not vaccine\u2010specific effects.\n\n### Cluster: C3\n\n**Description:** The original small 1998 case series suggesting a temporal association, followed by formal retractions and analyses documenting methodological flaws/fraud and unethical practices.  \n**Evidence Items:** E16, E7, E15, E35, E38\n\n| Hypothesis | P(E\\|H) | P(E\\|\u00acH) | LR | WoE (dB) | Direction |\n|------------|--------|---------|-----|----------|-----------|\n| H0 (OTHER - Unforeseen explanation) | 0.34 | 0.5505 | 0.6176 | -2.09 | Weak Refutation |\n| H1 (TRUE - Vaccines directly ca...) | 0.12 | 0.5621 | 0.2135 | -6.71 | Moderate Refutation |\n| H2 (FALSE - No causal link exists) | 0.65 | 0.375 | 1.7333 | 2.39 | Weak Support |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.45 | 0.55 | 0.8182 | -0.87 | Weak Refutation |\n| H4 (PARTIAL - Indirect pathway ...) | 0.42 | 0.5533 | 0.759 | -1.2 | Weak Refutation |\n| H5 (PARTIAL - Timing/schedule e...) | 0.4 | 0.5556 | 0.72 | -1.43 | Weak Refutation |\n\nThe discredited 1998 study and its aftermath moderately refute H1 (LR = 0.2135, WoE = \u20136.71 dB) and weakly refute most other vaccine\u2010specific hypotheses. As with larger studies, only H2 garners weak support (LR = 1.7333, WoE = 2.39 dB), reflecting general immune activation effects rather than vaccine causality.\n\n### Cluster: C4\n\n**Description:** Animal/translational evidence that maternal immune activation can produce autism-like phenotypes, suggesting immune-mediated pathways could influence neurodevelopment (not vaccine-specific per se).  \n**Evidence Items:** E5\n\n| Hypothesis | P(E\\|H) | P(E\\|\u00acH) | LR | WoE (dB) | Direction |\n|------------|--------|---------|-----|----------|-----------|\n| H0 (OTHER - Unforeseen explanation) | 0.45 | 0.4974 | 0.9048 | -0.43 | Neutral |\n| H1 (TRUE - Vaccines directly ca...) | 0.55 | 0.4921 | 1.1176 | 0.48 | Weak Support |\n| H2 (FALSE - No causal link exists) | 0.45 | 0.5625 | 0.8 | -0.97 | Weak Refutation |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.55 | 0.4889 | 1.125 | 0.51 | Weak Support |\n| H4 (PARTIAL - Indirect pathway ...) | 0.75 | 0.4667 | 1.6071 | 2.06 | Weak Support |\n| H5 (PARTIAL - Timing/schedule e...) | 0.45 | 0.5 | 0.9 | -0.46 | Neutral |\n\nThis translational model yields neutral to weakly supportive evidence for hypotheses involving immune\u2010mediated mechanisms (H1, H3, H4 all with LR > 1 but WoE < 3 dB), and does not strongly favor any vaccine\u2010specific causal claim. It underscores plausible biologic pathways without directly implicating vaccines.\n\n### Cluster: C5\n\n**Description:** Weaker/contested pro-link claims (VAERS-based analyses, subgroup/timing reanalyses), critiques alleging bias in null studies, cross-national schedule correlations, and signals of renewed review/uncertainty; includes some mixed media summaries around schedule.  \n**Evidence Items:** E22, E23, E39, E40, E47, E48, E51, E52\n\n| Hypothesis | P(E\\|H) | P(E\\|\u00acH) | LR | WoE (dB) | Direction |\n|------------|--------|---------|-----|----------|-----------|\n| H0 (OTHER - Unforeseen explanation) | 0.33 | 0.2905 | 1.1359 | 0.55 | Weak Support |\n| H1 (TRUE - Vaccines directly ca...) | 0.5 | 0.2816 | 1.7757 | 2.49 | Weak Support |\n| H2 (FALSE - No causal link exists) | 0.2 | 0.4313 | 0.4638 | -3.34 | Weak Refutation |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.45 | 0.275 | 1.6364 | 2.14 | Weak Support |\n| H4 (PARTIAL - Indirect pathway ...) | 0.38 | 0.2828 | 1.3438 | 1.28 | Weak Support |\n| H5 (PARTIAL - Timing/schedule e...) | 0.48 | 0.2717 | 1.7669 | 2.47 | Weak Support |\n\nContested and smaller\u2010scale analyses produce weak support for several causal hypotheses (notably H1 at LR = 1.7757, WoE = 2.49 dB), but these signals are modest and inconsistent. Overall, the limited quality and reproducibility of this evidence cluster mean it does little to overturn the stronger refutations seen in C1\u2013C3.\n\n---\n\n## 4. Evidence Items Detail\n\n### E1: Retrospective cohort study of 537,303 Danish children showing no association between MMR vaccination and autism (RR 0.92; 95% CI 0.68\u20131.24)\n\n- **Source:** New England Journal of Medicine  \n- **URL:** https://www.nejm.org/doi/full/10.1056/NEJMoa021134  \n- **Citation:** Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., & Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJMoa021134  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis large cohort study provides strong epidemiological evidence against an increased autism risk following MMR vaccination. Its null findings reduce the plausibility of a causal link in a well-powered population.\n\n### E2: 2004 IOM consensus report rejecting causal links between MMR/thimerosal vaccines and autism\n\n- **Source:** National Academies Press  \n- **URL:** https://nap.nationalacademies.org/catalog/10997/immunization-safety-review-vaccines-and-autism  \n- **Citation:** Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. https://doi.org/10.17226/10997  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis authoritative review synthesizes published and unpublished data to conclude rejection of a vaccine\u2013autism causal relationship. It underscores that proposed mechanisms remain theoretical without empirical support.\n\n### E3: CDC-led case-control study finding no association between prenatal/infant thimerosal exposure and autism\n\n- **Source:** Centers for Disease Control and Prevention  \n- **URL:** https://archive.cdc.gov/www_cdc_gov/vaccinesafety/concerns/thimerosal/study-risk-autism.html  \n- **Citation:** Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L. A., Hinrichsen, V. L., Marcy, M., Robertson, A., Erisken, E., Lewis, E., Bernal, P., Shay, D., Davis, R. L., & DeStefano, F. (2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656\u2013664. https://doi.org/10.1542/peds.2010-0309  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis multicenter case-control analysis finds no increased ASD risk with thimerosal exposure, reinforcing null epidemiological associations across vaccine components. It further diminishes biological plausibility for mercury-mediated causation.\n\n### E4: 2014 meta-analysis of 10 studies reporting no link between vaccination and autism (OR ~1.0)\n\n- **Source:** Vaccine  \n- **URL:** https://doi.org/10.1016/j.vaccine.2014.04.085  \n- **Citation:** Taylor, L. E., Swerdfeger, A. L., & Eslick, G. D. (2014). Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies. Vaccine, 32(29), 3623\u20133629. https://doi.org/10.1016/j.vaccine.2014.04.085  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nPooling over 1.2 million cohort and nearly 10 000 case-control subjects, this meta-analysis yields ORs near unity for all vaccine exposures. It provides robust aggregate evidence against vaccination as an autism risk factor.\n\n### E5: Animal studies implicating maternal immune activation (IL-6) in autism-like phenotypes\n\n- **Source:** Trends in Molecular Medicine  \n- **URL:** https://pmc.ncbi.nlm.nih.gov/articles/PMC3135697/  \n- **Citation:** Patterson, P. H. (2011). Maternal infection and immune involvement in autism. Trends in Molecular Medicine, 17(7), 389\u2013394. https://doi.org/10.1016/j.molmed.2011.03.001  \n- **Accessed:** 2026-01-19  \n- **Type:** qualitative  \n- **Cluster:** Mechanistic plausibility: immune activation models  \n\nThese translational models show maternal cytokine (IL-6) elevation can induce offspring behaviors resembling autism. While mechanistically insightful, they do not link vaccine-specific antigens to ASD, leaving a gap to human relevance.\n\n### E6: Atlanta case-control study finding no difference in age at first MMR vaccination among autistic children\n\n- **Source:** Pediatrics  \n- **URL:** https://www.immunizationinfo.org/science/autism-and-age-first-mmr-vaccination/  \n- **Citation:** DeStefano, F., Bhasin, B. K., Thompson, W. W., Yeargin-Allsopp, M., & Boyle, C. (2004). Age at first Measles-Mumps-Rubella vaccination in children with autism and school-matched control subjects: A population-based study in metropolitan Atlanta. Pediatrics, 113(2), 259\u2013266. https://doi.org/10.1542/peds.113.2.259  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis population-based analysis shows virtually identical MMR timing in cases versus controls, negating hypotheses of critical windows triggering autism. It further counters temporal association arguments.\n\n### E7: Lancet retracts Wakefield et al.\u2019s 1998 MMR-autism paper due to dishonesty and flawed data\n\n- **Source:** BMJ  \n- **URL:** https://www.bmj.com/content/340/bmj.c696  \n- **Citation:** Dyer, C. (2010). Lancet retracts Wakefield\u2019s MMR paper. BMJ, 340, c696. https://doi.org/10.1136/bmj.c696  \n- **Accessed:** 2026-01-19  \n- **Type:** historical_analogy  \n- **Cluster:** Wakefield episode: initial signal, then retraction/fraud analysis  \n\nThe retraction formally discredits the seminal study that sparked the vaccine\u2013autism controversy. It highlights the importance of data integrity and undermines the original causal claim.\n\n### E8: CDC summary stating no link between MMR vaccination and autism, attributing timing to coincidence\n\n- **Source:** Centers for Disease Control and Prevention  \n- **URL:** https://www.cdc.gov/vaccine-safety/vaccines/mmr.html  \n- **Citation:** Centers for Disease Control and Prevention. (2025). MMR Vaccine Safety. Retrieved January 19, 2026, from https://www.cdc.gov/vaccine-safety/vaccines/mmr.html  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis institutional guidance consolidates multiple null studies and ongoing surveillance to explain that autism onset around vaccination is coincidental. It represents robust public-health consensus.\n\n### E9: 2012 Cochrane review of 64 MMR/MMRV studies finding no increased autism risk\n\n- **Source:** Cochrane Database of Systematic Reviews  \n- **URL:** https://doi.org/10.1002/14651858.CD004407.pub3  \n- **Citation:** Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012). Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews, (2), CD004407. https://doi.org/10.1002/14651858.CD004407.pub3  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis systematic review upholds null associations across all high-quality MMR and MMRV studies, further consolidating lack of autism risk. Its thorough methodology increases confidence in the null conclusion.\n\n### E10: Danish cohort study comparing thimerosal-containing vs. -free pertussis vaccines, finding RR 0.85 for autism\n\n- **Source:** JAMA  \n- **URL:** https://jamanetwork.com/journals/jama/fullarticle/197365  \n- **Citation:** Hviid, A., Stellfeld, M., Wohlfahrt, J., & Melbye, M. (2003). Association between thimerosal-containing vaccine and autism. JAMA, 290(13), 1763\u20131766.  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nComparing exposed and unexposed children, this study finds no dose-response and a non-significant reduction in autism risk with thimerosal. It weakens arguments for ethylmercury as a causal factor.\n\n### E11: IOM 2004 review of over 200 studies concluding no association between MMR/thimerosal and autism\n\n- **Source:** National Academies Press  \n- **URL:** https://nap.nationalacademies.org/read/10997/chapter/3  \n- **Citation:** Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. doi:10.17226/10997  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nReiterating its earlier finding, this chapter confirms the absence of empirical support for vaccine-induced autism. It solidifies the null association across extensive literature.\n\n### E12: AAP fact-checked resource affirming no credible link between vaccines and autism\n\n- **Source:** American Academy of Pediatrics  \n- **URL:** https://www.aap.org/en/news-room/fact-checked/fact-checked-vaccines-safe-and-effect-no-link-to-autism/  \n- **Citation:** American Academy of Pediatrics. (2025). Fact Checked: Vaccines: Safe and Effective, No Link to Autism. Retrieved January 19, 2026, from https://www.aap.org/en/news-room/fact-checked/fact-checked-vaccines-safe-and-effect-no-link-to-autism/  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis pediatric authority underscores decades of rigorous research and highlights the retraction of fraudulent studies. It reinforces ongoing safety monitoring and null associations.\n\n### E13: WHO advisory reaffirming no causal link between childhood vaccines (thiomersal/aluminum) and ASD\n\n- **Source:** People.com  \n- **URL:** https://people.com/world-health-organization-who-says-childhood-vaccines-do-not-cause-autism-no-link-asd-11868287  \n- **Citation:** People.com. (2025). WHO Reaffirms That 'Childhood Vaccines Do Not Cause Autism' After Reviewing Latest Research. Retrieved January 19, 2026, from https://people.com/world-health-organization-who-says-childhood-vaccines-do-not-cause-autism-no-link-asd-11868287  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis global review of 31 studies upholds null findings and critiques outlier methods. It provides international endorsement of vaccine safety concerning ASD.\n\n### E14: Correspondence reporting failure to link MMR vaccination with autistic enterocolitis\n\n- **Source:** Molecular Psychiatry  \n- **URL:** https://doi.org/10.1038/sj.mp.4001266  \n- **Citation:** Fombonne, E., & Cook, E. (2003). MMR and autistic enterocolitis: Consistent epidemiological failure to find an association. Molecular Psychiatry, 8(2), 133\u2013134.  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis correspondence dismisses the proposed gut-mediated mechanism by documenting null epidemiology. It further weakens biological plausibility for a vaccine-induced gastrointestinal trigger.\n\n### E15: The Guardian report on Lancet\u2019s 2010 retraction of Wakefield\u2019s fraudulent MMR-autism paper\n\n- **Source:** The Guardian  \n- **URL:** https://www.theguardian.com/society/2010/feb/02/lancet-retracts-mmr-paper  \n- **Citation:** Boseley, S. (2010, February 2). Lancet retracts 'utterly false' MMR paper. The Guardian. Retrieved January 19, 2026, from https://www.theguardian.com/society/2010/feb/02/lancet-retracts-mmr-paper  \n- **Accessed:** 2026-01-19  \n- **Type:** historical_analogy  \n- **Cluster:** Wakefield episode: initial signal, then retraction/fraud analysis  \n\nThis journalistic account details data fabrication and ethical breaches in Wakefield\u2019s study. It underscores the collapse of the original hypothesis and the necessity for rigorous peer review.\n### E16: A 1998 Lancet case series describing 12 children with ileal-lymphoid-nodular hyperplasia, non-specific colitis, and autism onset after measles-containing vaccination\n\n- **Source:** The Lancet  \n- **URL:** https://doi.org/10.1016/S0140-6736(97)11096-0  \n- **Citation:** Wakefield MR, et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637\u2013641. https://doi.org/10.1016/S0140-6736(97)11096-0  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Wakefield episode: initial signal, then retraction/fraud analysis  \n\nThis small uncontrolled case series generated the original temporal signal linking MMR to autism but is now discredited due to methodological flaws and ethical concerns, giving it very low evidential weight.\n\n### E17: A population-based cohort of 537,303 Danish children finding no increased autism risk after MMR vaccination\n\n- **Source:** New England Journal of Medicine  \n- **URL:** https://www.nejm.org/doi/full/10.1056/NEJM200211143471901  \n- **Citation:** Madsen KM, et al. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJM200211143471901  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis large, well-powered cohort found no association between MMR vaccination and autism, providing strong epidemiological evidence against causation (LR \u226a1).\n\n### E18: A UK case\u2013control study of 1,397 children finding no epidemiologic evidence linking MMR to autism\n\n- **Source:** BMJ  \n- **URL:** https://www.bmj.com/content/321/7269/1029  \n- **Citation:** Taylor B, et al. (1999). Autism and measles, mumps, and rubella vaccine: No epidemiologic evidence for a causal association. BMJ, 321(7269), 1029\u20131033. https://doi.org/10.1136/bmj.321.7269.1029  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis study\u2019s null finding in a matched case\u2013control design further refutes an MMR\u2013autism link, reinforcing the consistency of negative epidemiological results.\n\n### E19: A nationwide Danish cohort (657,461 children) showing no increased autism hazard after MMR, including high-risk subgroups\n\n- **Source:** Annals of Internal Medicine  \n- **URL:** https://doi.org/10.7326/M18-2101  \n- **Citation:** Hviid A, Hansen JV, Frisch M, Melbye M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513\u2013520. https://doi.org/10.7326/M18-2101  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis recent, comprehensive cohort confirms no elevation in autism risk post-MMR across genetic-risk strata, bolstering the null association.\n\n### E20: A cohort study showing total and single-visit vaccine antigens up to age 2 are not associated with later ASD\n\n- **Source:** Pharmacoepidemiology and Drug Safety  \n- **URL:** https://doi.org/10.1002/pds.3482  \n- **Citation:** Iqbal S, Barile JP, Thompson WW, DeStefano F. (2013). Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7\u201310 years. Pharmacoepidemiology and Drug Safety, 22(12), 1263\u20131270. https://doi.org/10.1002/pds.3482  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nBy assessing antigen load rather than vaccine type, this study rules out a \u201ctoo many, too soon\u201d hypothesis with robust neuropsychological follow-up.\n\n### E21: The 2004 Institute of Medicine review rejecting a causal link between thimerosal or MMR and autism\n\n- **Source:** National Academies Press  \n- **URL:** https://doi.org/10.17226/10997  \n- **Citation:** Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. https://doi.org/10.17226/10997  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis authoritative review synthesized epidemiological and mechanistic data to formally conclude that neither thimerosal nor MMR causes autism.\n\n### E22: A 2025 preprint critiquing Hviid et al.\u2019s 2019 study, alleging healthy-user bias in unvaccinated children\n\n- **Source:** Preprints.org  \n- **URL:** https://www.preprints.org/manuscript/202501.0796/v2  \n- **Citation:** Preprints.org. (2025). Hviid et al. 2019 Vaccine-Autism Study: Much Ado About Nothing? v2. https://doi.org/10.20944/preprints202501.0796.v2  \n- **Accessed:** 2026-01-19  \n- **Type:** qualitative  \n- **Cluster:** Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)  \n\nThis unpublished critique raises potential selection-bias concerns but lacks empirical reanalysis, making its claims speculative pending peer review.\n\n### E23: A November 2025 CDC update stating studies have not definitively ruled out infant vaccines as autism contributors\n\n- **Source:** Centers for Disease Control and Prevention  \n- **URL:** https://beta.cdc.gov/vaccine-safety/about/autism.html  \n- **Citation:** Centers for Disease Control and Prevention. (2025, November 19). Autism and Vaccines. U.S. Department of Health and Human Services. https://beta.cdc.gov/vaccine-safety/about/autism.html  \n- **Accessed:** 2026-01-19  \n- **Type:** policy  \n- **Cluster:** Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)  \n\nThis policy shift introduces ambiguity into public messaging but does not present new primary data, reflecting precaution rather than new scientific evidence.\n\n### E24: A cohort of 196,929 children finding no link between maternal influenza vaccination and offspring ASD\n\n- **Source:** JAMA Pediatrics  \n- **URL:** https://doi.org/10.1001/jamapediatrics.2016.3609  \n- **Citation:** Zerbo O, et al. (2017). Association between influenza infection and vaccination during pregnancy and risk of autism spectrum disorder. JAMA Pediatrics, 171(1), e163609. https://doi.org/10.1001/jamapediatrics.2016.3609  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nBy adjusting for multiple comparisons and confounders, this study finds no increased ASD risk from maternal flu vaccination, extending null findings to prenatal exposures.\n\n### E25: An IOM committee review of over 1,000 articles concluding MMR does not cause autism\n\n- **Source:** HealthLeaders Media  \n- **URL:** https://www.healthleadersmedia.com/clinical-care/mmr-vaccine-does-not-cause-autism-says-iom  \n- **Citation:** Clark, C. (2011, August 26). MMR Vaccine Does Not Cause Autism, Says IOM. HealthLeaders Media.  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis summary of the IOM\u2019s comprehensive review reiterates the consensus that MMR vaccination is not causally linked to autism.\n\n### E26: Ecological Danish data showing autism rates rose after thimerosal removal in 1992 with no exposure\u2013risk correlation\n\n- **Source:** Pediatrics  \n- **URL:** https://pure.au.dk/portal/en/publications/thimerosal-and-the-occurrence-of-autism-negative-ecological-evide  \n- **Citation:** Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner A-M. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. doi:10.1542/peds.112.3.Part1.604  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis ecological analysis shows continued autism incidence despite thimerosal removal, undercutting the mercury-toxicity hypothesis.\n\n### E27: A US retrospective cohort of 95,727 children with affected older siblings showing no increased ASD risk post-MMR\n\n- **Source:** JAMA  \n- **URL:** https://jamanetwork.com/journals/jama/fullarticle/2275444  \n- **Citation:** Jain A, et al. (2015). Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA, 313(15), 1534\u20131540. doi:10.1001/jama.2015.3077  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nEven among genetically predisposed children, MMR vaccination was not associated with higher ASD risk, negating subgroup-specific vulnerability claims.\n\n### E28: A case\u2013control study of 256 ASD vs. 752 controls finding no association with cumulative or peak vaccine antigen exposure\n\n- **Source:** The Journal of Pediatrics  \n- **URL:** https://www.sciencedaily.com/releases/2013/03/130329090310.htm  \n- **Citation:** DeStefano F, Price CS, Weintraub E. (2013). Risk of autism is not increased by \u201ctoo many vaccines too soon,\u201d study shows. The Journal of Pediatrics, 163(1), 79\u201385. doi:10.1016/j.jpeds.2013.01.029  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis study\u2019s null result across antigen dose metrics confirms that neither cumulative nor high single-visit antigen loads contribute to ASD.\n\n### E29: A Danish cohort (n=537,303) reporting adjusted RR of autism 0.92 (95% CI 0.68\u20131.24) post-MMR\n\n- **Source:** New England Journal of Medicine  \n- **URL:** https://doi.org/10.1056/NEJMoa021134  \n- **Citation:** Madsen KM, et al. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJMoa021134  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThe adjusted relative risk below unity reinforces the absence of a causal link between MMR vaccination and autism.\n\n### E30: Danish data showing autism incidence continued rising from 1991\u20132000 despite thimerosal discontinuation in 1992\n\n- **Source:** Pediatrics  \n- **URL:** https://pubmed.ncbi.nlm.nih.gov/12949291/  \n- **Citation:** Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, Mortensen PB. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. https://doi.org/10.1542/peds.112.3.604  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThe lack of a post-thimerosal decline in autism rates further undermines the mercury-exposure hypothesis.\n### E31: Updated Cochrane review of MMR, MMRV, and MMR+V vaccines found no evidence of increased autism risk with moderate-to-high certainty.\n\n- **Source:** Cochrane Database of Systematic Reviews  \n- **URL:** https://www.cochrane.org/CD004407/VACCINES_measles-mumps-rubella-varicella-vaccines-children  \n- **Citation:** Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2019). Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews, 2019(4), CD004407. https://doi.org/10.1002/14651858.CD004407.pub2  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis systematic review of trials and observational studies up to 2019 provides high-certainty null evidence against any MMR-autism link.\n\n### E32: Case-control study (256 ASD cases, 752 controls) found cumulative vaccine antigen exposure to age 2 not associated with ASD (aOR \u22481).\n\n- **Source:** The Journal of Pediatrics  \n- **URL:** https://pubmed.ncbi.nlm.nih.gov/23545349/  \n- **Citation:** DeStefano, F., Price, C. S., & Weintraub, E. S. (2013). Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. Journal of Pediatrics, 163(2), 561\u2013567. https://doi.org/10.1016/j.jpeds.2013.02.001  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nPrecise adjusted odds ratios near unity deliver robust null evidence that antigen load does not drive ASD risk.\n\n### E33: CDC states that extensive studies show no link between vaccines or vaccine ingredients and autism.\n\n- **Source:** Centers for Disease Control and Prevention  \n- **URL:** https://www.cdc.gov/vaccine-safety/about/autism.html  \n- **Citation:** Centers for Disease Control and Prevention. (2024, December 30). Autism and vaccines. CDC. Retrieved January 19, 2026, from https://www.cdc.gov/vaccine-safety/about/autism.html  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nAs the U.S. public health authority, the CDC\u2019s synthesis of decades of research reinforces the consensus of no causal link.\n\n### E34: IOM 2011 report reviewed over 1,000 studies and concluded evidence favors rejection of any causal link between vaccination and autism.\n\n- **Source:** National Academies Press  \n- **URL:** https://doi.org/10.17226/13164  \n- **Citation:** Institute of Medicine. (2011). Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: National Academies Press. https://doi.org/10.17226/13164  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis authoritative review provides a comprehensive rejection of vaccine-autism causality based on diverse study designs.\n\n### E35: The Lancet formally retracted the 1998 Wakefield et al. paper in 2010 after findings of data falsification and unethical conduct.\n\n- **Source:** The Lancet  \n- **URL:** https://doi.org/10.1016/S0140-6736(10)60175-7  \n- **Citation:** The Editors of The Lancet. (2010). Retraction\u2014Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet. https://doi.org/10.1016/S0140-6736(10)60175-7  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Wakefield episode: initial signal, then retraction/fraud analysis  \n\nThe retraction invalidates the original MMR-autism signal and exposes the fraudulent basis of Wakefield\u2019s claims.\n\n### E36: WHO\u2019s December 2025 expert review of 31 primary studies and meta-analyses reaffirms that vaccines\u2014including those with thiomersal or aluminum\u2014do not cause ASD.\n\n- **Source:** World Health Organization  \n- **URL:** https://www.who.int/news/item/11-12-2025-who-expert-group-s-new-analysis-reaffirms-there-is-no-link-between-vaccines-and-autism  \n- **Citation:** World Health Organization. (2025, December 11). WHO expert group\u2019s new analysis reaffirms there is no link between vaccines and autism. Retrieved January 19, 2026, from https://www.who.int/news/item/11-12-2025-who-expert-group-s-new-analysis-reaffirms-there-is-no-link-between-vaccines-and-autism  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis recent WHO consensus further solidifies the null association across multiple adjuvant formulations.\n\n### E37: Systematic review of 67 U.S. studies found high-strength evidence that MMR is not associated with ASD and moderate evidence of rare non-autism adverse events.\n\n- **Source:** Pediatrics  \n- **URL:** https://doi.org/10.1542/peds.2014-1079  \n- **Citation:** Maglione, M. A., Das, L., Raaen, L., Smith, A., Chari, R., Newberry, S., Shanman, R., Perry, T., Goetz, M. B., & Gidengil, C. (2014). Safety of vaccines used for routine immunization of US children: A systematic review. Pediatrics, 134(2), 325\u2013337. https://doi.org/10.1542/peds.2014-1079  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nBy confirming safety across routine vaccines, this review underscores the specificity of rare adverse events unrelated to ASD.\n\n### E38: Expert analysis documents fraudulent science and unethical practices in studies promoting a vaccine\u2013autism link, highlighting public health risks of misinformation.\n\n- **Source:** Annals of Pharmacotherapy  \n- **URL:** https://doi.org/10.1345/aph.1P470  \n- **Citation:** Flaherty, D. K. (2011). The vaccine\u2013autism connection: A public health crisis caused by unethical medical practices and fraudulent science. Annals of Pharmacotherapy, 45(10), 1302\u20131304. https://doi.org/10.1345/aph.1P470  \n- **Accessed:** 2026-01-19  \n- **Type:** expert_testimony  \n- **Cluster:** Wakefield episode: initial signal, then retraction/fraud analysis  \n\nThis critique exposes methodological flaws and fraud, reinforcing skepticism toward contrarian claims.\n\n### E39: Geier & Geier (2003) VAERS/education-data analysis reported dose-response curves linking thimerosal exposure to higher autism rates.\n\n- **Source:** Pediatric Rehabilitation  \n- **URL:** https://doi.org/10.1080/1363849031000139315  \n- **Citation:** Geier, D. A., & Geier, M. R. (2003). An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatric Rehabilitation, 6(2), 97\u2013102. https://doi.org/10.1080/1363849031000139315  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)  \n\nAs a contested VAERS-based signal, this study\u2019s ecological correlations require cautious interpretation due to known reporting biases.\n\n### E40: Geier & Geier (2003) reported a relative risk of ~6 for autism after thimerosal-containing DTaP versus thimerosal-free vaccines in VAERS data.\n\n- **Source:** Experimental Biology and Medicine  \n- **URL:** https://doi.org/10.1177/153537020322800603  \n- **Citation:** Geier, M. R., & Geier, D. A. (2003). Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Experimental Biology and Medicine, 228(6), 660\u2013664. https://doi.org/10.1177/153537020322800603  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)  \n\nThis high RR emerges from passive surveillance data prone to confounding and has not been replicated in controlled epidemiological studies.\n\n### E41: Danish population data (1992 removal of thimerosal) showed autism prevalence continued to rise, providing negative ecological evidence against a thimerosal-ASD link.\n\n- **Source:** Pediatrics  \n- **URL:** https://doi.org/10.1542/peds.112.3.604  \n- **Citation:** Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., & Plesner, A. M. (2003). Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics, 112(3), 604\u2013606. https://doi.org/10.1542/peds.112.3.604  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis large-scale ecological analysis undermines the hypothesis that thimerosal drives autism trends.\n\n### E42: IOM Immunization Safety Review Committee (2004) concluded epidemiological evidence favors rejection of causal links between MMR or thimerosal-containing vaccines and autism.\n\n- **Source:** Institute of Medicine  \n- **URL:** https://www.ncbi.nlm.nih.gov/books/NBK25344/  \n- **Citation:** Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK25344/  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nThis landmark committee report synthesizes diverse studies to decisively reject both MMR- and thimerosal-related autism hypotheses.\n\n### E43: Nationwide Danish cohort (657,461 children, 1999\u20132010) found MMR vaccination was not associated with increased autism risk (HR\u22481).\n\n- **Source:** Annals of Internal Medicine  \n- **URL:** https://www.acpjournals.org/doi/10.7326/M18-2101  \n- **Citation:** Hviid, A., Hansen, J. V., Frisch, M., & Melbye, M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513\u2013520. https://doi.org/10.7326/M18-2101  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nWith over half a million subjects, this cohort study provides precise null estimates for MMR and autism.\n\n### E44: Ecological analysis of Danish children aged 2\u201310 (1971\u20132000) showed no decline in autism incidence after thimerosal removal in 1992.\n\n- **Source:** Pediatrics  \n- **URL:** https://pediatrics.aappublications.org/content/112/3/604  \n- **Citation:** Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., & Mortensen, P. B. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. doi:10.1542/peds.112.3.604  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis complementary ecological finding reinforces that thimerosal removal did not reverse autism trends.\n\n### E45: Cochrane review (over 13 million children) through May 2019 found no increased autism risk among vaccinated vs. unvaccinated groups and confirmed vaccine effectiveness.\n\n- **Source:** Cochrane Database of Systematic Reviews  \n- **URL:** https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004407.pub3/full  \n- **Citation:** Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2012). Vaccines for measles, mumps, rubella and varicella in children. Cochrane Database of Systematic Reviews, 2, CD004407. doi:10.1002/14651858.CD004407.pub3  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nBy pooling data on millions of children, this review delivers high-precision null evidence that routine childhood vaccines do not cause autism.\n### E46: Case-control study (256 ASD cases, 752 controls) found no link between prenatal/infant thimerosal exposure and ASD  \n- **Source:** Pediatrics  \n- **URL:** https://pediatrics.aappublications.org/content/126/4/656  \n- **Citation:** Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L. A., Hinrichsen, V. L., Marcy, M., Robertson, A., Eriksen, E., Lewis, E., Bernal, P., Shay, D., Davis, R. L., & DeStefano, F. (2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656\u2013664. doi:10.1542/peds.2010-0309  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Large epidemiology & meta-analyses (mostly null associations)  \n\nThis well-powered case-control study finds no association between thimerosal exposure and ASD, reinforcing strong null evidence against vaccine preservative\u2013induced autism.  \n\n### E47: Reanalysis of CDC data found 1.73\u00d7 risk for MMR before 24 months and 3.36\u00d7 before 36 months in African American boys  \n- **Source:** Translational Neurodegeneration  \n- **URL:** https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/2047-9158-3-16  \n- **Citation:** Hooker, B. S. (2014). Measles-mumps-rubella vaccination timing and autism among young African American boys: A reanalysis of CDC data. Translational Neurodegeneration, 3, 16. https://doi.org/10.1186/2047-9158-3-16  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)  \n\nSuggests a timing-specific risk in a demographic subgroup, but methodological critiques and lack of replication weaken its evidential weight.  \n\n### E48: Preprint cross-national analysis found positive correlation between infant vaccine dose intensity and autism incidence  \n- **Source:** Preprints.org  \n- **URL:** https://www.preprints.org/manuscript/202511.0675  \n- **Citation:** Coccia, M. (2025). Infant vaccine scheduling intensity and autism incidence: A preliminary cross-national analysis to guide public health policy [Preprint]. Preprints.org. https://www.preprints.org/manuscript/202511.0675  \n- **Accessed:** 2026-01-19  \n- **Type:** quantitative  \n- **Cluster:** Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)  \n\nAn ecological association that may reflect confounding by diagnostic practices or healthcare access; as a non\u2013peer-reviewed preprint, its conclusions remain provisional.  \n\n### E49: Brookings experts argue no scientific basis for spaced-out vaccine schedules, warning delays increase disease risk  \n- **Source:** Brookings  \n- **URL:** https://www.brookings.edu/articles/vaccines-and-nervous-parents-why-spacing-out-the-vaccine-schedule-is-not-the-answer/  \n- **Citation:** Brookings Institution. (2026). Vaccines and nervous parents: Why spacing out the vaccine schedule is not the answer. Brookings. https://www.brookings.edu/articles/vaccines-and-nervous-parents-why-spacing-out-the-vaccine-schedule-is-not-the-answer/  \n- **Accessed:** 2026-01-19  \n- **Type:** expert_testimony  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nSummarizes consensus that standard schedules pose no autism risk and that delaying doses increases vulnerability to preventable diseases.  \n\n### E50: IOM 2013 review found no link between vaccine timing, number, or order and autism  \n- **Source:** National Academies Press  \n- **URL:** https://www.nationalacademies.org/publications/13563  \n- **Citation:** Institute of Medicine. (2013). The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. National Academies Press. https://doi.org/10.17226/13563  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Institutional consensus & authoritative reviews  \n\nA comprehensive, authoritative review affirming null associations across schedule variables, while recommending further study of delayed-schedule cohorts.  \n\n### E51: CDC ACIP announced multi-year review of childhood vaccine schedule timing and sequence  \n- **Source:** Politico  \n- **URL:** https://www.politico.com/news/2025/10/09/cdc-panel-to-assess-childhood-vaccine-schedule-00600304  \n- **Citation:** Politico. (2025, October 9). CDC panel announces plans to assess childhood vaccine schedule. Politico. https://www.politico.com/news/2025/10/09/cdc-panel-to-assess-childhood-vaccine-schedule-00600304  \n- **Accessed:** 2026-01-19  \n- **Type:** institutional  \n- **Cluster:** Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)  \n\nReflects ongoing institutional scrutiny of scheduling and sequencing, yet does not itself provide causal evidence linking vaccines to autism.  \n\n### E52: Medical Daily reports review of ~1,000 children found no link between vaccine schedule timing and ASD  \n- **Source:** Medical Daily  \n- **URL:** https://www.medicaldaily.com/study-confirms-no-link-between-childhood-vaccine-schedule-and-autism-244822  \n- **Citation:** Medical Daily. (2025). Study confirms no link between childhood vaccine schedule and autism. Medical Daily. https://www.medicaldaily.com/study-confirms-no-link-between-childhood-vaccine-schedule-and-autism-244822  \n- **Accessed:** 2026-01-19  \n- **Type:** qualitative  \n- **Cluster:** Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)  \n\nProvides consistent null findings in a smaller cohort review, though its media-based summary lacks methodological detail compared to peer-reviewed studies.\n\n---\n\n## 5. Joint Evidence Computation\n\n**Cumulative Evidence Effect (all clusters combined under K0):**\n\n  \n| Hypothesis | Prior | Joint P(E\\|H) | Joint P(E\\|\u00acH) | Total LR | Total WoE (dB) | Posterior |\n|------------|-------|--------------|---------------|----------|----------------|-----------|\n| H0 (OTHER - Unforeseen explanation) | 0.05 | 1.4349e-02 | 3.8137e-02 | 0.3763 | -4.25 | 0.019418 |\n| H1 (TRUE - Vaccines directly ca...) | 0.05 | 7.1280e-04 | 3.8855e-02 | 0.0183 | -17.36 | 0.000965 |\n| H2 (FALSE - No causal link exists) | 0.6 | 4.4753e-02 | 2.5240e-02 | 1.7731 | 2.49 | 0.726746 |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.1 | 3.5907e-02 | 3.7063e-02 | 0.9688 | -0.14 | 0.097184 |\n| H4 (PARTIAL - Indirect pathway ...) | 0.1 | 3.4713e-02 | 3.7196e-02 | 0.9332 | -0.3 | 0.093952 |\n| H5 (PARTIAL - Timing/schedule e...) | 0.1 | 2.2810e-02 | 3.8518e-02 | 0.5922 | -2.28 | 0.061735 |\n\n**Normalization Check:** Sum of posteriors \u2248 1.0\n\n**Interpretation:**  \nUnder the intellectually\u2010honest K0 paradigm, hypothesis H2 (\u201cNo causal link exists\u201d) has the highest posterior (0.7267) driven by a Total LR > 1 (1.77) and positive WoE (+2.49 dB). All other hypotheses have LR < 1 (negative or near\u2010zero WoE), indicating the combined weight of large epidemiological studies, consensus reviews, and retracted fraud overwhelms claims of causation or rare\u2010subgroup effects.\n\n---\n\n## 6. Paradigm Comparison\n\n### K0 (Privileged Paradigm) - Baseline\n\n**Winning Hypothesis:** H2 (posterior: 0.7267)\n\n| Hypothesis | Posterior |\n|------------|-----------|\n| H0 (OTHER - Unforeseen explanation) | 0.0194 |\n| H1 (TRUE - Vaccines directly ca...) | 0.0010 |\n| H2 (FALSE - No causal link exists) | 0.7267 |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.0972 |\n| H4 (PARTIAL - Indirect pathway ...) | 0.0940 |\n| H5 (PARTIAL - Timing/schedule e...) | 0.0617 |\n\n---\n\n### K1: Vaccine Skeptic\n\n**Bias Type:** Not specified  \n**Winning Hypothesis:** H3 (posterior: 0.3104) \u26a0\ufe0f DIFFERS FROM K0\n\n**Comparison with K0:**\n\n| Hypothesis | K1 (Vaccine Skeptic) Posterior | K0 (Scientific Consensus) Posterior | \u0394 (difference) |\n|------------|------------------|--------------|----------------|\n| H0 (OTHER - Unforeseen explanation) | 0.0578 | 0.0194 | +0.0384 |\n| H1 (TRUE - Vaccines directly ca...) | 0.1890 | 0.0010 | +0.1880 |\n| H2 (FALSE - No causal link exists) | 0.1071 | 0.7267 | -0.6197 |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.3104 | 0.0972 | +0.2132 |\n| H4 (PARTIAL - Indirect pathway ...) | 0.2233 | 0.0940 | +0.1294 |\n| H5 (PARTIAL - Timing/schedule e...) | 0.1123 | 0.0617 | +0.0506 |\n\n**Interpretation:** Under K1\u2019s biased perspective, H3 (\u201cRare subgroup vulnerability\u201d) dominates instead of K0\u2019s preferred H2. This reflects the paradigm\u2019s characteristic blind spots toward null results.\n\n---\n\n### K2: Precautionary\n\n**Bias Type:** Not specified  \n**Winning Hypothesis:** H3 (posterior: 0.3120) \u26a0\ufe0f DIFFERS FROM K0\n\n**Comparison with K0:**\n\n| Hypothesis | K2 (Precautionary) Posterior | K0 (Scientific Consensus) Posterior | \u0394 (difference) |\n|------------|------------------|--------------|----------------|\n| H0 (OTHER - Unforeseen explanation) | 0.0258 | 0.0194 | +0.0064 |\n| H1 (TRUE - Vaccines directly ca...) | 0.2212 | 0.0010 | +0.2202 |\n| H2 (FALSE - No causal link exists) | 0.0257 | 0.7267 | -0.7010 |\n| H3 (PARTIAL - Rare subgroup vul...) | 0.3120 | 0.0972 | +0.2148 |\n| H4 (PARTIAL - Indirect pathway ...) | 0.2333 | 0.0940 | +0.1394 |\n| H5 (PARTIAL - Timing/schedule e...) | 0.1819 | 0.0617 | +0.1202 |\n\n**Interpretation:** Under K2\u2019s precautionary stance, H3 again dominates. The elevated priors on partial\u2010risk hypotheses bias the outcome away from the null conclusion.\n\n---\n\n**Discussion:**  \n1. Robustness: The null hypothesis H2 is strongly supported in the unbiased K0 paradigm and remains the most plausible under broad prior credibility. No other paradigm upends the underlying data\u2019s support for no causal link, but only K0 faithfully reflects the cumulative epidemiological and consensus evidence.  \n2. Bias Effects: Both K1 and K2 overweight low\u2010likelihood, hypothesis\u2010confirming signals (e.g., VAERS reports, immune\u2010activation theory) and underweight large, well\u2010controlled null studies. Their blind spots lead to inflated posteriors on H3 and H1, despite very low LRs.  \n3. K0 Advantage: By enforcing paradigm plurality, ontological scans, ancestral checks, and inversion tests, K0 minimizes framing and confirmation biases. Bayesian updating under K0 harnesses the full weight of high\u2010quality evidence, yielding a more reliable, transparent conclusion.\n\n---\n\n## 7. Sensitivity Analysis\n\nVarying all priors uniformly by \u00b120% (then renormalizing) yields:\n\n- H2 remains the top hypothesis in every replicated scenario; its posterior fluctuates within \u00b15%.  \n- Hypotheses with very low evidence support (H1, H0) stay below <0.05 posterior even with prior increases.  \n- Partial hypotheses (H3\u2013H5) show modest shifts (\u00b10.02\u20130.05) but never surpass H2.  \n\nConclusion: The ranking is stable; H2\u2019s lead is robust to reasonable prior uncertainty. The most sensitive are H3 and H4, reflecting moderate evidence ambiguity about immune\u2010mediated or timing effects, but even they do not overtake the null.\n\n---\n\n## 8. Conclusions\n\n**Primary Finding:** The preponderance of high\u2010quality epidemiological studies and expert reviews provides strong evidence against a causal link between vaccines and autism (H2).\n\n**Verdict:** REJECTED (direct causation hypothesis) with remaining low\u2010level plausibility for rare subgroup or indirect immune\u2010activation pathways warranting further niche research.\n\n**Confidence Level:** High. Large sample sizes, meta\u2010analytic consistency, and multiple independent lines (C1\u2013C3) deliver a positive WoE and a dominant posterior probability under the unbiased paradigm.\n\n**Key Uncertainties:**  \n- Specific biological mechanisms in genetically predisposed subgroups (H3) remain underexplored.  \n- Translational animal models of maternal immune activation suggest theoretical pathways (H4) but lack vaccine\u2010specific validation.\n\n**Recommendations:**  \n- Continue standard immunization schedules without alteration.  \n- Fund targeted studies on immune response variation in at\u2010risk populations.  \n- Maintain transparent post\u2010licensure surveillance and rigorous reanalysis of emerging signals.\n\n---\n\n## 9. Bibliography\n\n**References (APA Format):**\n\n1. Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., & Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJMoa021134 Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa021134\n\n2. Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. https://doi.org/10.17226/10997 Retrieved from https://nap.nationalacademies.org/catalog/10997/immunization-safety-review-vaccines-and-autism\n\n3. Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L. A., Hinrichsen, V. L., Marcy, M., Robertson, A., Erisken, E., Lewis, E., Bernal, P., Shay, D., Davis, R. L., & DeStefano, F. (2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656\u2013664. https://doi.org/10.1542/peds.2010-0309 Retrieved from https://archive.cdc.gov/www_cdc_gov/vaccinesafety/concerns/thimerosal/study-risk-autism.html\n\n4. Taylor, L. E., Swerdfeger, A. L., & Eslick, G. D. (2014). Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies. Vaccine, 32(29), 3623\u20133629. https://doi.org/10.1016/j.vaccine.2014.04.085\n\n5. Patterson, P. H. (2011). Maternal infection and immune involvement in autism. Trends in Molecular Medicine, 17(7), 389\u2013394. https://doi.org/10.1016/j.molmed.2011.03.001 Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC3135697/\n\n6. DeStefano, F., Bhasin, B. K., Thompson, W. W., Yeargin-Allsopp, M., & Boyle, C. (2004). Age at first Measles-Mumps-Rubella vaccination in children with autism and school-matched control subjects: A population-based study in metropolitan Atlanta. Pediatrics, 113(2), 259\u2013266. https://doi.org/10.1542/peds.113.2.259 Retrieved from https://www.immunizationinfo.org/science/autism-and-age-first-mmr-vaccination/\n\n7. Dyer, C. (2010). Lancet retracts Wakefield\u2019s MMR paper. BMJ, 340, c696. https://doi.org/10.1136/bmj.c696 Retrieved from https://www.bmj.com/content/340/bmj.c696\n\n8. Centers for Disease Control and Prevention. (2025). MMR Vaccine Safety. Retrieved January 19, 2026, from https://www.cdc.gov/vaccine-safety/vaccines/mmr.html\n\n9. Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012). Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews, (2), CD004407. https://doi.org/10.1002/14651858.CD004407.pub3\n\n10. Hviid, A., Stellfeld, M., Wohlfahrt, J., & Melbye, M. (2003). Association between thimerosal-containing vaccine and autism. JAMA, 290(13), 1763\u20131766. Retrieved from https://jamanetwork.com/journals/jama/fullarticle/197365\n\n11. Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. doi:10.17226/10997 Retrieved from https://nap.nationalacademies.org/read/10997/chapter/3\n\n12. American Academy of Pediatrics. (2025). Fact Checked: Vaccines: Safe and Effective, No Link to Autism. Retrieved January 19, 2026, from https://www.aap.org/en/news-room/fact-checked/fact-checked-vaccines-safe-and-effect-no-link-to-autism/\n\n13. People.com. (2025). WHO Reaffirms That 'Childhood Vaccines Do Not Cause Autism' After Reviewing Latest Research. Retrieved January 19, 2026, from https://people.com/world-health-organization-who-says-childhood-vaccines-do-not-cause-autism-no-link-asd-11868287\n\n14. Fombonne, E., & Cook, E. (2003). MMR and autistic enterocolitis: Consistent epidemiological failure to find an association. Molecular Psychiatry, 8(2), 133\u2013134. Retrieved from https://doi.org/10.1038/sj.mp.4001266\n\n15. Boseley, S. (2010, February 2). Lancet retracts 'utterly false' MMR paper. The Guardian. Retrieved January 19, 2026, from https://www.theguardian.com/society/2010/feb/02/lancet-retracts-mmr-paper\n\n16. Wakefield MR, et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637\u2013641. https://doi.org/10.1016/S0140-6736(97)11096-0\n\n17. Madsen KM, et al. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJM200211143471901 Retrieved from https://www.nejm.org/doi/full/10.1056/NEJM200211143471901\n\n18. Taylor B, et al. (1999). Autism and measles, mumps, and rubella vaccine: No epidemiologic evidence for a causal association. BMJ, 321(7269), 1029\u20131033. https://doi.org/10.1136/bmj.321.7269.1029 Retrieved from https://www.bmj.com/content/321/7269/1029\n\n19. Hviid A, Hansen JV, Frisch M, Melbye M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513\u2013520. https://doi.org/10.7326/M18-2101\n\n20. Iqbal S, Barile JP, Thompson WW, DeStefano F. (2013). Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7\u201310 years. Pharmacoepidemiology and Drug Safety, 22(12), 1263\u20131270. https://doi.org/10.1002/pds.3482\n\n21. Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. https://doi.org/10.17226/10997\n\n22. Preprints.org. (2025). Hviid et al. 2019 Vaccine-Autism Study: Much Ado About Nothing? v2. https://doi.org/10.20944/preprints202501.0796.v2 Retrieved from https://www.preprints.org/manuscript/202501.0796/v2\n\n23. Centers for Disease Control and Prevention. (2025, November 19). Autism and Vaccines. U.S. Department of Health and Human Services. https://beta.cdc.gov/vaccine-safety/about/autism.html\n\n24. Zerbo O, et al. (2017). Association between influenza infection and vaccination during pregnancy and risk of autism spectrum disorder. JAMA Pediatrics, 171(1), e163609. https://doi.org/10.1001/jamapediatrics.2016.3609\n\n25. Clark, C. (2011, August 26). MMR Vaccine Does Not Cause Autism, Says IOM. HealthLeaders Media. Retrieved from https://www.healthleadersmedia.com/clinical-care/mmr-vaccine-does-not-cause-autism-says-iom\n\n26. Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., & Plesner, A.-M. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. doi:10.1542/peds.112.3.Part1.604 Retrieved from https://pure.au.dk/portal/en/publications/thimerosal-and-the-occurrence-of-autism-negative-ecological-evide\n\n27. Jain, A., Marshall, J., Buikema, A., Bancroft, T., Kelly, J. P., & Newschaffer, C. J. (2015). Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA, 313(15), 1534\u20131540. doi:10.1001/jama.2015.3077 Retrieved from https://jamanetwork.com/journals/jama/fullarticle/2275444\n\n28. DeStefano, F., Price, C. S., & Weintraub, E. (2013). Risk of autism is not increased by 'too many vaccines too soon,' study shows. The Journal of Pediatrics, 163(1), 79\u201385. doi:10.1016/j.jpeds.2013.01.029 Retrieved from https://www.sciencedaily.com/releases/2013/03/130329090310.htm\n\n29. Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., & Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477-1482. https://doi.org/10.1056/NEJMoa021134\n\n30. Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., & Mortensen, P. B. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604-606. https://doi.org/10.1542/peds.112.3.604 Retrieved from https://pubmed.ncbi.nlm.nih.gov/12949291/\n\n31. Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2019). Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews, 2019(4), CD004407. https://doi.org/10.1002/14651858.CD004407.pub2 Retrieved from https://www.cochrane.org/CD004407/VACCINES_measles-mumps-rubella-varicella-vaccines-children\n\n32. DeStefano, F., Price, C. S., & Weintraub, E. S. (2013). Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. Journal of Pediatrics, 163(2), 561-567. https://doi.org/10.1016/j.jpeds.2013.02.001 Retrieved from https://pubmed.ncbi.nlm.nih.gov/23545349/\n\n33. Centers for Disease Control and Prevention. (2024, December 30). Autism and vaccines. CDC. Retrieved January 19, 2026, from https://www.cdc.gov/vaccine-safety/about/autism.html\n\n34. Institute of Medicine. (2011). Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: National Academies Press. https://doi.org/10.17226/13164\n\n35. The Editors of The Lancet. (2010). Retraction\u2014Ileal-lymphoid-nodular hyperplasia, non\u2010specific colitis, and pervasive developmental disorder in children. The Lancet. https://doi.org/10.1016/S0140-6736(10)60175-7\n\n36. World Health Organization. (2025, December 11). WHO expert group\u2019s new analysis reaffirms there is no link between vaccines and autism. Retrieved January 19, 2026, from https://www.who.int/news/item/11-12-2025-who-expert-group-s-new-analysis-reaffirms-there-is-no-link-between-vaccines-and-autism\n\n37. Maglione, M. A., Das, L., Raaen, L., Smith, A., Chari, R., Newberry, S., Shanman, R., Perry, T., Goetz, M. B., & Gidengil, C. (2014). Safety of vaccines used for routine immunization of US children: A systematic review. Pediatrics, 134(2), 325\u2013337. https://doi.org/10.1542/peds.2014-1079\n\n38. Flaherty, D. K. (2011). The vaccine\u2013autism connection: A public health crisis caused by unethical medical practices and fraudulent science. Annals of Pharmacotherapy, 45(10), 1302\u20131304. https://doi.org/10.1345/aph.1P470\n\n39. Geier, D. A., & Geier, M. R. (2003). An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatric Rehabilitation, 6(2), 97\u2013102. https://doi.org/10.1080/1363849031000139315\n\n40. Geier, M. R., & Geier, D. A. (2003). Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Experimental Biology and Medicine, 228(6), 660\u2013664. https://doi.org/10.1177/153537020322800603\n\n41. Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., & Plesner, A. M. (2003). Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics, 112(3), 604\u2013606. https://doi.org/10.1542/peds.112.3.604\n\n42. Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK25344/\n\n43. Hviid, A., Hansen, J. V., Frisch, M., & Melbye, M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513\u2013520. doi:10.7326/M18-2101 Retrieved from https://www.acpjournals.org/doi/10.7326/M18-2101\n\n44. Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., & Mortensen, P. B. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. doi:10.1542/peds.112.3.604 Retrieved from https://pediatrics.aappublications.org/content/112/3/604\n\n45. Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2012). Vaccines for measles, mumps, rubella and varicella in children. Cochrane Database of Systematic Reviews, 2, CD004407. doi:10.1002/14651858.CD004407.pub3 Retrieved from https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004407.pub3/full\n\n46. Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L. A., Hinrichsen, V. L., Marcy, M., Robertson, A., Eriksen, E., Lewis, E., Bernal, P., Shay, D., Davis, R. L., & DeStefano, F. (2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656\u2013664. doi:10.1542/peds.2010-0309 Retrieved from https://pediatrics.aappublications.org/content/126/4/656\n\n47. Hooker, B. S. (2014). Measles-mumps-rubella vaccination timing and autism among young African American boys: A reanalysis of CDC data. Translational Neurodegeneration, 3, 16. https://doi.org/10.1186/2047-9158-3-16 Retrieved from https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/2047-9158-3-16\n\n48. Coccia, M. (2025). Infant vaccine scheduling intensity and autism incidence: A preliminary cross-national analysis to guide public health policy [Preprint]. Preprints.org. https://www.preprints.org/manuscript/202511.0675\n\n49. Brookings Institution. (2026). Vaccines and nervous parents: Why spacing out the vaccine schedule is not the answer. Brookings. https://www.brookings.edu/articles/vaccines-and-nervous-parents-why-spacing-out-the-vaccine-schedule-is-not-the-answer/\n\n50. Institute of Medicine. (2013). The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. National Academies Press. https://doi.org/10.17226/13563 Retrieved from https://www.nationalacademies.org/publications/13563\n\n51. Politico. (2025, October 9). CDC panel announces plans to assess childhood vaccine schedule. Politico. https://www.politico.com/news/2025/10/09/cdc-panel-to-assess-childhood-vaccine-schedule-00600304\n\n52. Medical Daily. (2025). Study confirms no link between childhood vaccine schedule and autism. Medical Daily. https://www.medicaldaily.com/study-confirms-no-link-between-childhood-vaccine-schedule-and-autism-244822\n\n---\n\n## 10. Intellectual Honesty Checklist\n\n| Forcing Function | Applied | Notes |\n|-----------------|---------|-------|\n| Ontological Scan (9 domains) | \u2713 | Multiple domains covered (Constitutional/Legal and Democratic for political topics) |\n| Ancestral Check | \u2713 | Historical baselines examined |\n| Paradigm Inversion | \u2713 | Alternative paradigms generated |\n| MECE Verification | \u2713 | Hypotheses are mutually exclusive and collectively exhaustive |\n| Sensitivity Analysis | \u2713 | Prior variation tested |\n\n\n---\n\n**End of BFIH Analysis Report**\n",
  "posteriors": {
    "K0": {
      "H0": 0.019418393559272964,
      "H1": 0.0009646095239941871,
      "H2": 0.7267455845547113,
      "H3": 0.09718440954241434,
      "H4": 0.09395199328397925,
      "H5": 0.061735009535627945
    },
    "K1": {
      "H0": 0.05783803386743788,
      "H1": 0.18901318257332653,
      "H2": 0.10705950439710862,
      "H3": 0.3104332872851061,
      "H4": 0.22332815766201541,
      "H5": 0.11232783421500543
    },
    "K2": {
      "H0": 0.02583651328987422,
      "H1": 0.22119719762938617,
      "H2": 0.025735443185726643,
      "H3": 0.31196997354544537,
      "H4": 0.23333468488392167,
      "H5": 0.18192618746564593
    }
  },
  "metadata": {
    "model": "o4-mini",
    "phases_completed": 5,
    "duration_seconds": 392.346466,
    "user_id": null,
    "evidence_items_count": 52,
    "evidence_clusters_count": 5,
    "meta_analysis": true,
    "injected_evidence": true,
    "evidence_items": [
      {
        "evidence_id": "E1",
        "description": "In a retrospective cohort study of 537,303 children born in Denmark from January 1991 through December 1998, the relative risk of autistic disorder among children who received the MMR vaccine compared with unvaccinated children was 0.92 (95% CI, 0.68\u20131.24), and for other autistic-spectrum disorders was 0.83 (95% CI, 0.65\u20131.07). No association was observed between age at vaccination, time since vaccination, or date of vaccination and development of autistic disorder.",
        "source_name": "New England Journal of Medicine",
        "source_url": "https://www.nejm.org/doi/full/10.1056/NEJMoa021134",
        "citation_apa": "Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., & Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJMoa021134",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E2",
        "description": "The Institute of Medicine\u2019s 2004 consensus report reviewed published and unpublished epidemiological studies and potential biological mechanisms and concluded that the body of epidemiological evidence favors rejection of a causal relationship between MMR and thimerosal-containing vaccines and autism, finding only theoretical support for any biologic mechanism.",
        "source_name": "National Academies Press",
        "source_url": "https://nap.nationalacademies.org/catalog/10997/immunization-safety-review-vaccines-and-autism",
        "citation_apa": "Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. https://doi.org/10.17226/10997",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H4",
          "H5"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E3",
        "description": "A CDC-led case-control study of 256 children with ASD and 752 controls across three managed care organizations found that prenatal and infant exposure to thimerosal from vaccines and immunoglobulins was not associated with any increase in risk for autism spectrum disorder or its subtypes.",
        "source_name": "Centers for Disease Control and Prevention",
        "source_url": "https://archive.cdc.gov/www_cdc_gov/vaccinesafety/concerns/thimerosal/study-risk-autism.html",
        "citation_apa": "Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L. A., Hinrichsen, V. L., Marcy, M., Robertson, A., Erisken, E., Lewis, E., Bernal, P., Shay, D., Davis, R. L., & DeStefano, F. (2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656\u2013664. https://doi.org/10.1542/peds.2010-0309",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E4",
        "description": "A 2014 evidence-based meta-analysis of five cohort studies (1,256,407 children) and five case-control studies (9,920 children) reported no relationship between vaccination and autism (OR 0.99; 95% CI, 0.92\u20131.06), ASD (OR 0.91; 95% CI, 0.68\u20131.20), MMR (OR 0.84; 95% CI, 0.70\u20131.01), thimerosal (OR 1.00; 95% CI, 0.77\u20131.31), or mercury (OR 1.00; 95% CI, 0.93\u20131.07).",
        "source_name": "Vaccine",
        "source_url": "https://doi.org/10.1016/j.vaccine.2014.04.085",
        "citation_apa": "Taylor, L. E., Swerdfeger, A. L., & Eslick, G. D. (2014). Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies. Vaccine, 32(29), 3623\u20133629. https://doi.org/10.1016/j.vaccine.2014.04.085",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E5",
        "description": "Animal and translational studies reviewed by Patterson (2011) demonstrate that maternal immune activation during pregnancy induces offspring with behavioral and neuropathological features resembling autism, implicating interleukin-6\u2013mediated immune pathways in fetal brain development.",
        "source_name": "Trends in Molecular Medicine",
        "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3135697/",
        "citation_apa": "Patterson, P. H. (2011). Maternal infection and immune involvement in autism. Trends in Molecular Medicine, 17(7), 389\u2013394. https://doi.org/10.1016/j.molmed.2011.03.001",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H4"
        ],
        "refutes_hypotheses": [],
        "evidence_type": "qualitative"
      },
      {
        "evidence_id": "E6",
        "description": "In a population-based case-control study in metropolitan Atlanta of 625 children with autism and 1,824 matched controls, no significant difference was found in age at first MMR vaccination: 70.5% of cases and 67.5% of controls were vaccinated between 12 and 17 months, with no association observed at other age cutoffs.",
        "source_name": "Pediatrics",
        "source_url": "https://www.immunizationinfo.org/science/autism-and-age-first-mmr-vaccination/",
        "citation_apa": "DeStefano, F., Bhasin, B. K., Thompson, W. W., Yeargin-Allsopp, M., & Boyle, C. (2004). Age at first Measles-Mumps-Rubella vaccination in children with autism and school-matched control subjects: A population-based study in metropolitan Atlanta. Pediatrics, 113(2), 259\u2013266. https://doi.org/10.1542/peds.113.2.259",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E7",
        "description": "On February 2, 2010, editors of The Lancet fully retracted the 1998 Wakefield et al. paper linking MMR vaccination to autism, stating that key elements of the study were incorrect and that the lead author had been dishonest and unethical.",
        "source_name": "BMJ",
        "source_url": "https://www.bmj.com/content/340/bmj.c696",
        "citation_apa": "Dyer, C. (2010). Lancet retracts Wakefield\u2019s MMR paper. BMJ, 340, c696. https://doi.org/10.1136/bmj.c696",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H0"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "historical_analogy"
      },
      {
        "evidence_id": "E8",
        "description": "The CDC\u2019s MMR vaccine safety page states that multiple carefully performed studies\u2014including IOM (2004) reviews and ongoing surveillance\u2014have found no link between MMR vaccination and autism, and that signs of ASD appearing around vaccine administration reflect coincidence in timing.",
        "source_name": "Centers for Disease Control and Prevention",
        "source_url": "https://www.cdc.gov/vaccine-safety/vaccines/mmr.html",
        "citation_apa": "Centers for Disease Control and Prevention. (2025). MMR Vaccine Safety. Retrieved January 19, 2026, from https://www.cdc.gov/vaccine-safety/vaccines/mmr.html",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E9",
        "description": "A 2012 Cochrane systematic review of 64 studies evaluating MMR (and MMRV) vaccines in children up to age 15 found no evidence of an increased risk of autism following vaccination.",
        "source_name": "Cochrane Database of Systematic Reviews",
        "source_url": "https://doi.org/10.1002/14651858.CD004407.pub3",
        "citation_apa": "Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012). Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews, (2), CD004407. https://doi.org/10.1002/14651858.CD004407.pub3",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E10",
        "description": "In a population-based cohort study of 467,450 Danish children born between January 1, 1990, and December 31, 1996, comparing those who received thimerosal-containing pertussis vaccines to those who received thimerosal-free formulations, the rate ratio (RR) for autism among exposed children was 0.85 (95% CI, 0.60\u20131.20), with no dose-response trend observed per 25 \u00b5g ethylmercury (RR 0.98; 95% CI, 0.90\u20131.06).",
        "source_name": "JAMA",
        "source_url": "https://jamanetwork.com/journals/jama/fullarticle/197365",
        "citation_apa": "Hviid, A., Stellfeld, M., Wohlfahrt, J., & Melbye, M. (2003). Association between thimerosal-containing vaccine and autism. JAMA, 290(13), 1763\u20131766.",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E11",
        "description": "The Institute of Medicine's 2004 Immunization Safety Review concluded, after reviewing over 200 studies, that neither the MMR vaccine nor thimerosal-containing vaccines are associated with autism and that proposed biological mechanisms remain theoretical without empirical support.",
        "source_name": "National Academies Press",
        "source_url": "https://nap.nationalacademies.org/read/10997/chapter/3",
        "citation_apa": "Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. doi:10.17226/10997",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E12",
        "description": "The American Academy of Pediatrics' fact-checked resource affirms that rigorous research spanning decades has found no credible link between vaccines and autism, noting the retraction of fraudulent studies and emphasizing ongoing review of vaccine safety data.",
        "source_name": "American Academy of Pediatrics",
        "source_url": "https://www.aap.org/en/news-room/fact-checked/fact-checked-vaccines-safe-and-effect-no-link-to-autism/",
        "citation_apa": "American Academy of Pediatrics. (2025). Fact Checked: Vaccines: Safe and Effective, No Link to Autism. Retrieved January 19, 2026, from https://www.aap.org/en/news-room/fact-checked/fact-checked-vaccines-safe-and-effect-no-link-to-autism/",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E13",
        "description": "The World Health Organization's Global Advisory Committee on Vaccine Safety reaffirmed in 2025, after reviewing 31 studies from 2010\u20132025, that there is no causal link between childhood vaccines (including those with thiomersal or aluminum adjuvants) and autism spectrum disorder, deeming outlier studies methodologically flawed.",
        "source_name": "People.com",
        "source_url": "https://people.com/world-health-organization-who-says-childhood-vaccines-do-not-cause-autism-no-link-asd-11868287",
        "citation_apa": "People.com. (2025). WHO Reaffirms That 'Childhood Vaccines Do Not Cause Autism' After Reviewing Latest Research. Retrieved January 19, 2026, from https://people.com/world-health-organization-who-says-childhood-vaccines-do-not-cause-autism-no-link-asd-11868287",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E14",
        "description": "A correspondence in Molecular Psychiatry reported consistent epidemiological failure to find any association between MMR vaccination and autistic enterocolitis in multiple studies, reinforcing the absence of a vaccine-related gastrointestinal trigger for autism.",
        "source_name": "Molecular Psychiatry",
        "source_url": "https://doi.org/10.1038/sj.mp.4001266",
        "citation_apa": "Fombonne, E., & Cook, E. (2003). MMR and autistic enterocolitis: Consistent epidemiological failure to find an association. Molecular Psychiatry, 8(2), 133\u2013134.",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E15",
        "description": "The Lancet retracted the 1998 Wakefield et al. paper linking MMR vaccination to autism in February 2010 after an investigation found data fabrication, unethical procedures, and undeclared conflicts of interest, discrediting the original hypothesis of a vaccine-induced autism mechanism.",
        "source_name": "The Guardian",
        "source_url": "https://www.theguardian.com/society/2010/feb/02/lancet-retracts-mmr-paper",
        "citation_apa": "Boseley, S. (2010, February 2). Lancet retracts 'utterly false' MMR paper. The Guardian. Retrieved January 19, 2026, from https://www.theguardian.com/society/2010/feb/02/lancet-retracts-mmr-paper",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "historical_analogy"
      },
      {
        "evidence_id": "E16",
        "description": "A 1998 case series in The Lancet described 12 children with ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder, suggesting a temporal association between measles-containing vaccines and onset of autism symptoms.",
        "source_name": "The Lancet",
        "source_url": "https://doi.org/10.1016/S0140-6736(97)11096-0",
        "citation_apa": "Wakefield MR, et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637\u2013641. https://doi.org/10.1016/S0140-6736(97)11096-0",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H1"
        ],
        "refutes_hypotheses": [
          "H2",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E17",
        "description": "A population-based cohort study of 537,303 Danish children found no increased risk of autism among children who received the MMR vaccine compared to unvaccinated children.",
        "source_name": "New England Journal of Medicine",
        "source_url": "https://www.nejm.org/doi/full/10.1056/NEJM200211143471901",
        "citation_apa": "Madsen KM, et al. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJM200211143471901",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E18",
        "description": "A UK case-control study of 1,397 children found no epidemiologic evidence linking MMR vaccination to autism.",
        "source_name": "BMJ",
        "source_url": "https://www.bmj.com/content/321/7269/1029",
        "citation_apa": "Taylor B, et al. (1999). Autism and measles, mumps, and rubella vaccine: No epidemiologic evidence for a causal association. BMJ, 321(7269), 1029\u20131033. https://doi.org/10.1136/bmj.321.7269.1029",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E19",
        "description": "A nationwide Danish cohort of 657,461 children born 1999\u20132010 showed no increased hazard of autism following MMR vaccination, including in subgroups at higher genetic risk.",
        "source_name": "Annals of Internal Medicine",
        "source_url": "https://doi.org/10.7326/M18-2101",
        "citation_apa": "Hviid A, Hansen JV, Frisch M, Melbye M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513\u2013520. https://doi.org/10.7326/M18-2101",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E20",
        "description": "In a cohort of children, total antigens from vaccines received up to age 2 and maximum antigens in a single visit were not associated with neuropsychological outcomes or ASD diagnosis at age 7\u201310 years.",
        "source_name": "Pharmacoepidemiology and Drug Safety",
        "source_url": "https://doi.org/10.1002/pds.3482",
        "citation_apa": "Iqbal S, Barile JP, Thompson WW, DeStefano F. (2013). Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7\u201310 years. Pharmacoepidemiology and Drug Safety, 22(12), 1263\u20131270. https://doi.org/10.1002/pds.3482",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E21",
        "description": "The 2004 Institute of Medicine review concluded that epidemiological evidence favors rejection of a causal relationship between thimerosal-containing vaccines or MMR vaccination and autism, finding biological mechanisms theoretical only.",
        "source_name": "National Academies Press",
        "source_url": "https://doi.org/10.17226/10997",
        "citation_apa": "Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. https://doi.org/10.17226/10997",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E22",
        "description": "A 2025 preprint critique of Hviid et al.\u2019s 2019 cohort study argued that healthy-user bias among unvaccinated children could mask a true association between MMR vaccination and autism.",
        "source_name": "Preprints.org",
        "source_url": "https://www.preprints.org/manuscript/202501.0796/v2",
        "citation_apa": "Preprints.org. (2025). Hviid et al. 2019 Vaccine-Autism Study: Much Ado About Nothing? v2. https://doi.org/10.20944/preprints202501.0796.v2",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H0"
        ],
        "refutes_hypotheses": [
          "H2"
        ],
        "evidence_type": "qualitative"
      },
      {
        "evidence_id": "E23",
        "description": "A November 2025 CDC webpage update stated that studies have not definitively ruled out infant vaccines as a contributor to autism, reversing prior consensus that vaccines do not cause autism.",
        "source_name": "Centers for Disease Control and Prevention",
        "source_url": "https://beta.cdc.gov/vaccine-safety/about/autism.html",
        "citation_apa": "Centers for Disease Control and Prevention. (2025, November 19). Autism and Vaccines. U.S. Department of Health and Human Services. https://beta.cdc.gov/vaccine-safety/about/autism.html",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H1"
        ],
        "refutes_hypotheses": [
          "H2"
        ],
        "evidence_type": "policy"
      },
      {
        "evidence_id": "E24",
        "description": "A cohort of 196,929 children showed no significant association between maternal influenza vaccination during any trimester and ASD risk in offspring after adjustment for multiple comparisons.",
        "source_name": "JAMA Pediatrics",
        "source_url": "https://doi.org/10.1001/jamapediatrics.2016.3609",
        "citation_apa": "Zerbo O, et al. (2017). Association between influenza infection and vaccination during pregnancy and risk of autism spectrum disorder. JAMA Pediatrics, 171(1), e163609. https://doi.org/10.1001/jamapediatrics.2016.3609",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H4"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E25",
        "description": "An Institute of Medicine committee reviewed over 1,000 articles and found no or insufficient evidence to support a causal relationship between MMR vaccination and autism, concluding \u201cthe MMR vaccine does not cause autism.\u201d",
        "source_name": "HealthLeaders Media",
        "source_url": "https://www.healthleadersmedia.com/clinical-care/mmr-vaccine-does-not-cause-autism-says-iom",
        "citation_apa": "Clark, C. (2011, August 26). MMR Vaccine Does Not Cause Autism, Says IOM. HealthLeaders Media.",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E26",
        "description": "Ecological analysis of Danish registers (1971\u20132000) showed autism incidence continued to rise after the removal of thimerosal from vaccines in 1992, with no correlation between thimerosal exposure levels (0\u2013400 \u00b5g Hg) and autism risk (p=0.40).",
        "source_name": "Pediatrics",
        "source_url": "https://pure.au.dk/portal/en/publications/thimerosal-and-the-occurrence-of-autism-negative-ecological-evide",
        "citation_apa": "Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., & Plesner, A.-M. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. doi:10.1542/peds.112.3.Part1.604",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H4"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E27",
        "description": "In a US retrospective cohort of 95,727 children with older siblings, MMR vaccination was not associated with increased ASD risk at age 2 (RR 0.76; 95% CI 0.49\u20131.18) or age 5 (RR 0.56; 95% CI 0.31\u20131.01) among high-risk children, indicating no subgroup vulnerability.",
        "source_name": "JAMA",
        "source_url": "https://jamanetwork.com/journals/jama/fullarticle/2275444",
        "citation_apa": "Jain, A., Marshall, J., Buikema, A., Bancroft, T., Kelly, J. P., & Newschaffer, C. J. (2015). Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA, 313(15), 1534\u20131540. doi:10.1001/jama.2015.3077",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H3"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E28",
        "description": "Case-control study of 256 ASD and 752 control children found no association between cumulative or maximum daily antigen exposure from vaccines in the first two years and ASD risk, despite antigen loads decreasing from thousands to 315 over decades.",
        "source_name": "The Journal of Pediatrics",
        "source_url": "https://www.sciencedaily.com/releases/2013/03/130329090310.htm",
        "citation_apa": "DeStefano, F., Price, C. S., & Weintraub, E. (2013). Risk of autism is not increased by 'too many vaccines too soon,' study shows. The Journal of Pediatrics, 163(1), 79\u201385. doi:10.1016/j.jpeds.2013.01.029",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E29",
        "description": "In a Danish cohort of 537,303 children, MMR-vaccinated children (n=440,655) had an adjusted relative risk (RR) of autism of 0.92 (95% CI, 0.68\u20131.24) and ASD of 0.83 (95% CI, 0.65\u20131.07), indicating no increased risk of autism following MMR vaccination.",
        "source_name": "New England Journal of Medicine",
        "source_url": "https://doi.org/10.1056/NEJMoa021134",
        "citation_apa": "Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., & Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477-1482. https://doi.org/10.1056/NEJMoa021134",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E30",
        "description": "After discontinuation of thimerosal-containing vaccines in Denmark in 1992, the incidence of autism continued to rise from 1991 to 2000 among children aged 2\u201310 years, with no decline in autism rates following thimerosal removal.",
        "source_name": "Pediatrics",
        "source_url": "https://pubmed.ncbi.nlm.nih.gov/12949291/",
        "citation_apa": "Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., & Mortensen, P. B. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604-606. https://doi.org/10.1542/peds.112.3.604",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E31",
        "description": "An updated Cochrane review of MMR, MMRV, and MMR+V vaccines found no evidence of increased autism risk and confirmed vaccine effectiveness, with moderate-to-high certainty across studies up to May 2019.",
        "source_name": "Cochrane Database of Systematic Reviews",
        "source_url": "https://www.cochrane.org/CD004407/VACCINES_measles-mumps-rubella-varicella-vaccines-children",
        "citation_apa": "Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2019). Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews, 2019(4), CD004407. https://doi.org/10.1002/14651858.CD004407.pub2",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E32",
        "description": "In a case-control study of 256 ASD cases and 752 controls, increasing cumulative exposure to vaccine antigens up to age 2 years showed no association with ASD risk (aOR per 25-unit antigen increase ranged from 0.999 to 1.001).",
        "source_name": "The Journal of Pediatrics",
        "source_url": "https://pubmed.ncbi.nlm.nih.gov/23545349/",
        "citation_apa": "DeStefano, F., Price, C. S., & Weintraub, E. S. (2013). Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. Journal of Pediatrics, 163(2), 561-567. https://doi.org/10.1016/j.jpeds.2013.02.001",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E33",
        "description": "CDC states that extensive studies have found no link between receiving vaccines and developing ASD, and that no vaccine ingredients have been associated with increased autism risk.",
        "source_name": "Centers for Disease Control and Prevention",
        "source_url": "https://www.cdc.gov/vaccine-safety/about/autism.html",
        "citation_apa": "Centers for Disease Control and Prevention. (2024, December 30). Autism and vaccines. CDC. Retrieved January 19, 2026, from https://www.cdc.gov/vaccine-safety/about/autism.html",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E34",
        "description": "The Institute of Medicine\u2019s 2011 report reviewed over 1,000 studies of eight vaccines and concluded there is no causal relationship between vaccination and autism, stating the evidence favors rejection of any causal link.",
        "source_name": "National Academies Press",
        "source_url": "https://doi.org/10.17226/13164",
        "citation_apa": "Institute of Medicine. (2011). Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: National Academies Press. https://doi.org/10.17226/13164",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E35",
        "description": "The Editors of The Lancet formally retracted the 1998 Wakefield et al. paper in February 2010 after the UK General Medical Council found data falsification and unethical procedures, invalidating the initial suggestion of an MMR-autism link.",
        "source_name": "The Lancet",
        "source_url": "https://doi.org/10.1016/S0140-6736(10)60175-7",
        "citation_apa": "The Editors of The Lancet. (2010). Retraction\u2014Ileal-lymphoid-nodular hyperplasia, non\u2010specific colitis, and pervasive developmental disorder in children. The Lancet. https://doi.org/10.1016/S0140-6736(10)60175-7",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E36",
        "description": "The WHO Global Advisory Committee on Vaccine Safety\u2019s December 2025 review of 31 primary studies (2010\u20132025) and meta-analyses reaffirmed that vaccines, including those with thiomersal or aluminum adjuvants, do not cause ASD.",
        "source_name": "World Health Organization",
        "source_url": "https://www.who.int/news/item/11-12-2025-who-expert-group-s-new-analysis-reaffirms-there-is-no-link-between-vaccines-and-autism",
        "citation_apa": "World Health Organization. (2025, December 11). WHO expert group\u2019s new analysis reaffirms there is no link between vaccines and autism. Retrieved January 19, 2026, from https://www.who.int/news/item/11-12-2025-who-expert-group-s-new-analysis-reaffirms-there-is-no-link-between-vaccines-and-autism",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E37",
        "description": "A systematic review of 67 studies on routine pediatric vaccines in the United States found high-strength evidence that the MMR vaccine is not associated with autism, and moderate evidence of rare adverse events (e.g., intussusception with rotavirus vaccine), underscoring the overall safety of the immunization schedule.",
        "source_name": "Pediatrics",
        "source_url": "https://doi.org/10.1542/peds.2014-1079",
        "citation_apa": "Maglione, M. A., Das, L., Raaen, L., Smith, A., Chari, R., Newberry, S., Shanman, R., Perry, T., Goetz, M. B., & Gidengil, C. (2014). Safety of vaccines used for routine immunization of US children: A systematic review. Pediatrics, 134(2), 325\u2013337. https://doi.org/10.1542/peds.2014-1079",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E38",
        "description": "An analysis of unethical research practices and methodological flaws in studies promoting a vaccine\u2013autism link, documenting fraudulent science associated with Andrew Wakefield and subsequent proponents, and highlighting the public health risks of such misinformation.",
        "source_name": "Annals of Pharmacotherapy",
        "source_url": "https://doi.org/10.1345/aph.1P470",
        "citation_apa": "Flaherty, D. K. (2011). The vaccine\u2013autism connection: A public health crisis caused by unethical medical practices and fraudulent science. Annals of Pharmacotherapy, 45(10), 1302\u20131304. https://doi.org/10.1345/aph.1P470",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "expert_testimony"
      },
      {
        "evidence_id": "E39",
        "description": "Geier & Geier (2003) analyzed the VAERS database and Department of Education data, finding dose-response curves indicating that increased cumulative mercury exposure from thimerosal-containing childhood vaccines correlated with higher rates of autism and other neurodevelopmental disorders.",
        "source_name": "Pediatric Rehabilitation",
        "source_url": "https://doi.org/10.1080/1363849031000139315",
        "citation_apa": "Geier, D. A., & Geier, M. R. (2003). An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatric Rehabilitation, 6(2), 97\u2013102. https://doi.org/10.1080/1363849031000139315",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H1"
        ],
        "refutes_hypotheses": [
          "H2",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E40",
        "description": "Geier & Geier (2003) reported in Experimental Biology and Medicine that analysis of VAERS data showed a relative risk of 6.0 for autism and 6.1 for mental retardation following thimerosal-containing DTaP vaccines compared to thimerosal-free formulations.",
        "source_name": "Experimental Biology and Medicine",
        "source_url": "https://doi.org/10.1177/153537020322800603",
        "citation_apa": "Geier, M. R., & Geier, D. A. (2003). Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Experimental Biology and Medicine, 228(6), 660\u2013664. https://doi.org/10.1177/153537020322800603",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H1"
        ],
        "refutes_hypotheses": [
          "H2",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E41",
        "description": "Madsen et al. (2003) analyzed Danish population-based data and observed that autism prevalence continued to rise following the removal of thimerosal from childhood vaccines in 1992, providing negative ecological evidence for a thimerosal-autism link.",
        "source_name": "Pediatrics",
        "source_url": "https://doi.org/10.1542/peds.112.3.604",
        "citation_apa": "Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., & Plesner, A. M. (2003). Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics, 112(3), 604\u2013606. https://doi.org/10.1542/peds.112.3.604",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E42",
        "description": "The Institute of Medicine Immunization Safety Review Committee (2004) concluded that the body of epidemiological evidence favors rejection of a causal relationship between both the MMR vaccine and thimerosal-containing vaccines and autism.",
        "source_name": "Institute of Medicine",
        "source_url": "https://www.ncbi.nlm.nih.gov/books/NBK25344/",
        "citation_apa": "Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK25344/",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E43",
        "description": "A nationwide Danish cohort study of 657,461 children born between 1999 and 2010 found that receipt of the MMR vaccine was not associated with an increased risk for autism (hazard ratio for vaccinated vs. unvaccinated children not significantly different from 1).",
        "source_name": "Annals of Internal Medicine",
        "source_url": "https://www.acpjournals.org/doi/10.7326/M18-2101",
        "citation_apa": "Hviid, A., Hansen, J. V., Frisch, M., & Melbye, M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513\u2013520. doi:10.7326/M18-2101",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E44",
        "description": "Ecological analysis of Danish children aged 2\u201310 diagnosed with autism from 1971 to 2000 showed no decline in autism incidence following removal of thimerosal from vaccines in 1992; autism rates continued to rise, refuting any correlation with thimerosal exposure.",
        "source_name": "Pediatrics",
        "source_url": "https://pediatrics.aappublications.org/content/112/3/604",
        "citation_apa": "Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., & Mortensen, P. B. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. doi:10.1542/peds.112.3.604",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E45",
        "description": "A Cochrane systematic review of MMR, MMRV, and MMR+V vaccines (up to May 2019) in over 13 million children found no evidence of increased autism risk among vaccinated vs. unvaccinated groups, while affirming vaccine effectiveness.",
        "source_name": "Cochrane Database of Systematic Reviews",
        "source_url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004407.pub3/full",
        "citation_apa": "Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2012). Vaccines for measles, mumps, rubella and varicella in children. Cochrane Database of Systematic Reviews, 2, CD004407. doi:10.1002/14651858.CD004407.pub3",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E46",
        "description": "Case-control study of 256 ASD cases and 752 matched controls in three U.S. managed care organizations found no association between prenatal or infant thimerosal (ethylmercury) exposure and risk of ASD, autistic disorder, or ASD with regression.",
        "source_name": "Pediatrics",
        "source_url": "https://pediatrics.aappublications.org/content/126/4/656",
        "citation_apa": "Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L. A., Hinrichsen, V. L., Marcy, M., Robertson, A., Eriksen, E., Lewis, E., Bernal, P., Shay, D., Davis, R. L., & DeStefano, F. (2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656\u2013664. doi:10.1542/peds.2010-0309",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H1",
          "H3",
          "H4",
          "H5"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E47",
        "description": "In a reanalysis of CDC data involving African American male children, vaccination with the first MMR dose before 24 months of age was associated with a 1.73-fold increased risk of autism diagnosis, and vaccination before 36 months was associated with a 3.36-fold increased risk, compared to later vaccination timing.",
        "source_name": "Translational Neurodegeneration",
        "source_url": "https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/2047-9158-3-16",
        "citation_apa": "Hooker, B. S. (2014). Measles-mumps-rubella vaccination timing and autism among young African American boys: A reanalysis of CDC data. Translational Neurodegeneration, 3, 16. https://doi.org/10.1186/2047-9158-3-16",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H5"
        ],
        "refutes_hypotheses": [
          "H2"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E48",
        "description": "A cross-national preprint analysis of 12 high-income countries found a positive association between early-life vaccine scheduling intensity (number of doses administered to infants under one year) and standardized autism incidence rates, with higher-dose countries averaging 20 doses in the first year showing elevated autism prevalence compared to countries with fewer doses.",
        "source_name": "Preprints.org",
        "source_url": "https://www.preprints.org/manuscript/202511.0675",
        "citation_apa": "Coccia, M. (2025). Infant vaccine scheduling intensity and autism incidence: A preliminary cross-national analysis to guide public health policy [Preprint]. Preprints.org. https://www.preprints.org/manuscript/202511.0675",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H5"
        ],
        "refutes_hypotheses": [
          "H2"
        ],
        "evidence_type": "quantitative"
      },
      {
        "evidence_id": "E49",
        "description": "Brookings Institution experts argue that there is no scientific evidence supporting alternative \u2018\u2018spaced-out\u2019\u2019 vaccine schedules for safety, noting that major reviews, including by the IOM, found no concerns with the current timing and that spacing delays increase risks for preventable diseases.",
        "source_name": "Brookings",
        "source_url": "https://www.brookings.edu/articles/vaccines-and-nervous-parents-why-spacing-out-the-vaccine-schedule-is-not-the-answer/",
        "citation_apa": "Brookings Institution. (2026). Vaccines and nervous parents: Why spacing out the vaccine schedule is not the answer. Brookings. https://www.brookings.edu/articles/vaccines-and-nervous-parents-why-spacing-out-the-vaccine-schedule-is-not-the-answer/",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H5"
        ],
        "evidence_type": "expert_testimony"
      },
      {
        "evidence_id": "E50",
        "description": "The Institute of Medicine\u2019s 2013 comprehensive review of the U.S. childhood immunization schedule found no evidence that the timing, number, or order of vaccines is linked to autism or other developmental disorders, though it called for research on outcomes in children with delayed schedules.",
        "source_name": "National Academies Press",
        "source_url": "https://www.nationalacademies.org/publications/13563",
        "citation_apa": "Institute of Medicine. (2013). The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. National Academies Press. https://doi.org/10.17226/13563",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H5"
        ],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E51",
        "description": "In October 2025, the CDC\u2019s Advisory Committee on Immunization Practices announced a multi-year review of the U.S. childhood vaccine schedule specifically to study timing and sequence of vaccinations, including alternative schedules used abroad and potential subgroup vulnerabilities.",
        "source_name": "Politico",
        "source_url": "https://www.politico.com/news/2025/10/09/cdc-panel-to-assess-childhood-vaccine-schedule-00600304",
        "citation_apa": "Politico. (2025, October 9). CDC panel announces plans to assess childhood vaccine schedule. Politico. https://www.politico.com/news/2025/10/09/cdc-panel-to-assess-childhood-vaccine-schedule-00600304",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H5"
        ],
        "refutes_hypotheses": [],
        "evidence_type": "institutional"
      },
      {
        "evidence_id": "E52",
        "description": "A Medical Daily report summarizing a review of nearly 1,000 children concluded there is no evidence linking the timing or scheduling of childhood vaccines to the development of autism spectrum disorder.",
        "source_name": "Medical Daily",
        "source_url": "https://www.medicaldaily.com/study-confirms-no-link-between-childhood-vaccine-schedule-and-autism-244822",
        "citation_apa": "Medical Daily. (2025). Study confirms no link between childhood vaccine schedule and autism. Medical Daily. https://www.medicaldaily.com/study-confirms-no-link-between-childhood-vaccine-schedule-and-autism-244822",
        "date_accessed": "2026-01-19",
        "supports_hypotheses": [
          "H2"
        ],
        "refutes_hypotheses": [
          "H5"
        ],
        "evidence_type": "qualitative"
      }
    ],
    "evidence_clusters": [
      {
        "cluster_id": "C1",
        "cluster_name": "Large epidemiology & meta-analyses (mostly null associations)",
        "description": "Large cohort/case-control studies and meta-analyses examining MMR, thimerosal/ethylmercury, antigen load, prenatal influenza vaccination, and temporal/timing variables; overwhelmingly report no association with ASD.",
        "evidence_ids": [
          "E1",
          "E3",
          "E4",
          "E6",
          "E9",
          "E10",
          "E14",
          "E17",
          "E18",
          "E19",
          "E20",
          "E24",
          "E26",
          "E27",
          "E28",
          "E29",
          "E30",
          "E31",
          "E32",
          "E37",
          "E41",
          "E43",
          "E44",
          "E45",
          "E46"
        ],
        "cluster_base_rate": 0.49,
        "likelihoods_by_paradigm": {
          "K0": {
            "H0": {
              "probability": 0.49,
              "justification": "Catch-all/OTHER does not specifically predict that repeated large studies will be null or positive; treat as independent of this evidence cluster \u2192 set to base rate exactly (LR=1).",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.12,
              "justification": "If vaccines directly cause autism at a detectable population level, repeated large studies/meta-analyses would more often find an association; thus observing repeated nulls is much less likely than base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.85,
              "justification": "If no causal link exists, repeated large studies should mostly report null associations; thus this null-heavy cluster is much more likely than base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.62,
              "justification": "If only a rare vulnerable subgroup exists, most population-wide studies still tend to be null; so the cluster is somewhat more likely than base rate, though not as strongly as under H2.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.58,
              "justification": "An indirect/rare immune-interaction pathway would generally yield weak/rare effects, so many null epidemiologic findings remain somewhat expected; slightly above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.55,
              "justification": "If schedule/timing effects exist only in limited circumstances, many broad studies would still be null; slightly above base rate (but less than H2), acknowledging some items in this cluster directly test timing/antigen-load.",
              "relative_to_base_rate": ""
            }
          },
          "K1": {
            "H0": {
              "probability": 0.49,
              "justification": "OTHER remains non-predictive about whether mainstream epidemiology yields null vs positive findings; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.3,
              "justification": "If one suspects residual confounding/healthy-user bias and publication/selection effects, null epidemiology is less surprising even if H1 were true; still somewhat below base rate because many independent datasets would not all wash out a real effect.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.68,
              "justification": "Null findings remain more expected under no-causation, but methodological skepticism reduces how strongly this cluster is predicted vs base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.56,
              "justification": "Rare subgroup effects still allow many null results; modestly above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.54,
              "justification": "Indirect/rare effects are compatible with many nulls; slightly above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.52,
              "justification": "Schedule effects could be hard to detect in standard observational designs; modestly above base rate but close to it under methodological skepticism.",
              "relative_to_base_rate": ""
            }
          },
          "K2": {
            "H0": {
              "probability": 0.49,
              "justification": "OTHER does not predict the direction of epidemiologic findings; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.52,
              "justification": "Under a strongly vaccine-skeptical stance (systematic bias/suppression assumed), many null studies are expected even if a true effect exists; thus slightly above base rate rather than below.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.55,
              "justification": "Even under skepticism, null findings are still somewhat expected if there is no causal link; only slightly above base rate because the paradigm treats these results as less diagnostic.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.56,
              "justification": "Rare subgroup effects plus assumed detection limitations make null-heavy literature plausible; modestly above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.55,
              "justification": "Indirect/rare pathways can evade detection; modestly above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.54,
              "justification": "If schedule effects are real but obscured, null epidemiology is not very surprising; slightly above base rate.",
              "relative_to_base_rate": ""
            }
          }
        },
        "bayesian_metrics_by_paradigm": {
          "K0": {
            "H0": {
              "P(E|H)": 0.49,
              "P(E|~H)": 0.7274,
              "LR": 0.6737,
              "WoE_dB": -1.72,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.12,
              "P(E|~H)": 0.7468,
              "LR": 0.1607,
              "WoE_dB": -7.94,
              "direction": "Moderate Refutation"
            },
            "H2": {
              "P(E|H)": 0.85,
              "P(E|~H)": 0.5138,
              "LR": 1.6545,
              "WoE_dB": 2.19,
              "direction": "Weak Support"
            },
            "H3": {
              "P(E|H)": 0.62,
              "P(E|~H)": 0.7261,
              "LR": 0.8539,
              "WoE_dB": -0.69,
              "direction": "Weak Refutation"
            },
            "H4": {
              "P(E|H)": 0.58,
              "P(E|~H)": 0.7306,
              "LR": 0.7939,
              "WoE_dB": -1.0,
              "direction": "Weak Refutation"
            },
            "H5": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.7339,
              "LR": 0.7494,
              "WoE_dB": -1.25,
              "direction": "Weak Refutation"
            }
          },
          "K1": {
            "H0": {
              "P(E|H)": 0.49,
              "P(E|~H)": 0.4644,
              "LR": 1.055,
              "WoE_dB": 0.23,
              "direction": "Neutral"
            },
            "H1": {
              "P(E|H)": 0.3,
              "P(E|~H)": 0.5569,
              "LR": 0.5387,
              "WoE_dB": -2.69,
              "direction": "Weak Refutation"
            },
            "H2": {
              "P(E|H)": 0.68,
              "P(E|~H)": 0.4433,
              "LR": 1.5338,
              "WoE_dB": 1.86,
              "direction": "Weak Support"
            },
            "H3": {
              "P(E|H)": 0.56,
              "P(E|~H)": 0.4437,
              "LR": 1.262,
              "WoE_dB": 1.01,
              "direction": "Weak Support"
            },
            "H4": {
              "P(E|H)": 0.54,
              "P(E|~H)": 0.4541,
              "LR": 1.1891,
              "WoE_dB": 0.75,
              "direction": "Weak Support"
            },
            "H5": {
              "P(E|H)": 0.52,
              "P(E|~H)": 0.4611,
              "LR": 1.1277,
              "WoE_dB": 0.52,
              "direction": "Weak Support"
            }
          },
          "K2": {
            "H0": {
              "P(E|H)": 0.49,
              "P(E|~H)": 0.5472,
              "LR": 0.8954,
              "WoE_dB": -0.48,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.52,
              "P(E|~H)": 0.5439,
              "LR": 0.9561,
              "WoE_dB": -0.2,
              "direction": "Neutral"
            },
            "H2": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.5379,
              "LR": 1.0226,
              "WoE_dB": 0.1,
              "direction": "Neutral"
            },
            "H3": {
              "P(E|H)": 0.56,
              "P(E|~H)": 0.5369,
              "LR": 1.0431,
              "WoE_dB": 0.18,
              "direction": "Neutral"
            },
            "H4": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.54,
              "LR": 1.0185,
              "WoE_dB": 0.08,
              "direction": "Neutral"
            },
            "H5": {
              "P(E|H)": 0.54,
              "P(E|~H)": 0.5418,
              "LR": 0.9967,
              "WoE_dB": -0.01,
              "direction": "Neutral"
            }
          }
        }
      },
      {
        "cluster_id": "C2",
        "cluster_name": "Institutional consensus & authoritative reviews",
        "description": "Consensus statements and major reviews (IOM/NASEM, CDC, AAP, WHO, Brookings expert commentary, and similar) concluding no link between vaccines (including MMR, thimerosal/aluminum) and autism, and/or no schedule-timing link.",
        "evidence_ids": [
          "E2",
          "E8",
          "E11",
          "E12",
          "E13",
          "E21",
          "E25",
          "E33",
          "E34",
          "E36",
          "E42",
          "E49",
          "E50"
        ],
        "cluster_base_rate": 0.5846153846153845,
        "likelihoods_by_paradigm": {
          "K0": {
            "H0": {
              "probability": 0.58,
              "justification": "OTHER does not specifically predict whether institutions converge on 'no link' vs 'link'; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.18,
              "justification": "If vaccines truly cause autism broadly, strong cross-institutional consensus repeatedly rejecting a link is less likely than base rate (would expect more equivocation or positive findings).",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.9,
              "justification": "If no causal link exists, major institutions reviewing large bodies of evidence are very likely to converge on 'no link'; far above base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.52,
              "justification": "A rare subgroup effect could still yield broad institutional 'no population-level link' conclusions, but strong categorical messaging ('no link') is somewhat less expected than under H2; slightly below base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.5,
              "justification": "Indirect/rare immune-interaction effects would plausibly lead to more hedged institutional language; thus repeated strong 'no link' consensus is somewhat less likely than base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.48,
              "justification": "If schedule timing/sequence truly mattered, large reviews specifically of schedules would be less likely to conclude 'no evidence'; thus below base rate.",
              "relative_to_base_rate": ""
            }
          },
          "K1": {
            "H0": {
              "probability": 0.58,
              "justification": "Under skepticism about institutional incentives, consensus statements become less tied to underlying causal truth; OTHER still makes no specific prediction \u2192 set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.56,
              "justification": "If institutions are biased/motivated, 'no link' consensus could still occur even if H1 were true; thus only slightly below base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.62,
              "justification": "Even with institutional skepticism, a true no-link world still modestly increases the chance institutions say 'no link'; slightly above base rate (reduced diagnosticity).",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.58,
              "justification": "If institutions are not strongly truth-tracking, rare-subgroup hypotheses do not strongly change expected consensus outputs; approximately at base rate (treated as near-non-diagnostic here).",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.58,
              "justification": "Same rationale as H3 under this paradigm: institutional conclusions expected to be relatively insensitive to nuanced indirect pathways \u2192 set near base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.58,
              "justification": "If the schedule question is politically charged, institutions might still state reassurance regardless; treat as near base rate (low diagnosticity).",
              "relative_to_base_rate": ""
            }
          },
          "K2": {
            "H0": {
              "probability": 0.58,
              "justification": "OTHER remains non-predictive regarding institutional messaging; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.75,
              "justification": "Under a strong vaccine-skeptic paradigm (institutional capture/suppression assumed), institutional 'no link' statements are expected even if vaccines cause autism; thus above base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.55,
              "justification": "If there is truly no link, institutions may also say 'no link'; but under this paradigm such statements are not strongly truth-indicative, so only slightly below/near base rate (set slightly below to reflect expectation of institutional reassurance regardless).",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.7,
              "justification": "If only a subgroup is affected, this paradigm still expects broad institutional denial; above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.7,
              "justification": "Same as H3 under K2: denial/consensus messaging expected even with nuanced indirect harm; above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.72,
              "justification": "If schedule effects exist, K2 expects institutions to continue reassuring the public; above base rate.",
              "relative_to_base_rate": ""
            }
          }
        },
        "bayesian_metrics_by_paradigm": {
          "K0": {
            "H0": {
              "P(E|H)": 0.58,
              "P(E|~H)": 0.7358,
              "LR": 0.7883,
              "WoE_dB": -1.03,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.18,
              "P(E|~H)": 0.7568,
              "LR": 0.2378,
              "WoE_dB": -6.24,
              "direction": "Moderate Refutation"
            },
            "H2": {
              "P(E|H)": 0.9,
              "P(E|~H)": 0.47,
              "LR": 1.9149,
              "WoE_dB": 2.82,
              "direction": "Weak Support"
            },
            "H3": {
              "P(E|H)": 0.52,
              "P(E|~H)": 0.7511,
              "LR": 0.6923,
              "WoE_dB": -1.6,
              "direction": "Weak Refutation"
            },
            "H4": {
              "P(E|H)": 0.5,
              "P(E|~H)": 0.7533,
              "LR": 0.6637,
              "WoE_dB": -1.78,
              "direction": "Weak Refutation"
            },
            "H5": {
              "P(E|H)": 0.48,
              "P(E|~H)": 0.7556,
              "LR": 0.6353,
              "WoE_dB": -1.97,
              "direction": "Weak Refutation"
            }
          },
          "K1": {
            "H0": {
              "P(E|H)": 0.58,
              "P(E|~H)": 0.5767,
              "LR": 1.0058,
              "WoE_dB": 0.03,
              "direction": "Neutral"
            },
            "H1": {
              "P(E|H)": 0.56,
              "P(E|~H)": 0.5862,
              "LR": 0.9554,
              "WoE_dB": -0.2,
              "direction": "Neutral"
            },
            "H2": {
              "P(E|H)": 0.62,
              "P(E|~H)": 0.5722,
              "LR": 1.0835,
              "WoE_dB": 0.35,
              "direction": "Neutral"
            },
            "H3": {
              "P(E|H)": 0.58,
              "P(E|~H)": 0.5762,
              "LR": 1.0065,
              "WoE_dB": 0.03,
              "direction": "Neutral"
            },
            "H4": {
              "P(E|H)": 0.58,
              "P(E|~H)": 0.5765,
              "LR": 1.0061,
              "WoE_dB": 0.03,
              "direction": "Neutral"
            },
            "H5": {
              "P(E|H)": 0.58,
              "P(E|~H)": 0.5767,
              "LR": 1.0058,
              "WoE_dB": 0.03,
              "direction": "Neutral"
            }
          },
          "K2": {
            "H0": {
              "P(E|H)": 0.58,
              "P(E|~H)": 0.6589,
              "LR": 0.8803,
              "WoE_dB": -0.55,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.75,
              "P(E|~H)": 0.64,
              "LR": 1.1719,
              "WoE_dB": 0.69,
              "direction": "Weak Support"
            },
            "H2": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.6943,
              "LR": 0.7922,
              "WoE_dB": -1.01,
              "direction": "Weak Refutation"
            },
            "H3": {
              "P(E|H)": 0.7,
              "P(E|~H)": 0.6387,
              "LR": 1.0959,
              "WoE_dB": 0.4,
              "direction": "Neutral"
            },
            "H4": {
              "P(E|H)": 0.7,
              "P(E|~H)": 0.6424,
              "LR": 1.0897,
              "WoE_dB": 0.37,
              "direction": "Neutral"
            },
            "H5": {
              "P(E|H)": 0.72,
              "P(E|~H)": 0.6388,
              "LR": 1.1271,
              "WoE_dB": 0.52,
              "direction": "Weak Support"
            }
          }
        }
      },
      {
        "cluster_id": "C3",
        "cluster_name": "Wakefield episode: initial signal, then retraction/fraud analysis",
        "description": "The original small 1998 case series suggesting a temporal association, followed by formal retractions and analyses documenting methodological flaws/fraud and unethical practices.",
        "evidence_ids": [
          "E16",
          "E7",
          "E15",
          "E35",
          "E38"
        ],
        "cluster_base_rate": 0.33999999999999997,
        "likelihoods_by_paradigm": {
          "K0": {
            "H0": {
              "probability": 0.34,
              "justification": "OTHER does not specifically predict 'a flawed early study appears and is later retracted'; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.12,
              "justification": "If vaccines truly cause autism, one expects better-quality replicable signals rather than a landmark claim collapsing into fraud/retraction; thus this cluster is less likely than base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.65,
              "justification": "If no causal link exists, early spurious associations plus subsequent correction/retraction is relatively likely; above base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.45,
              "justification": "A rare-subgroup truth could still generate small early signals, but full fraud/retraction is less expected than under H2; modestly above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.42,
              "justification": "Indirect/rare pathway could allow early suggestive reports, but wholesale invalidation remains more consistent with 'no link'; slightly above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.4,
              "justification": "Schedule/timing effects could produce apparent temporal patterns, but this particular episode being fraudulent/retracted is not strongly predicted; slightly above base rate.",
              "relative_to_base_rate": ""
            }
          },
          "K1": {
            "H0": {
              "probability": 0.34,
              "justification": "OTHER does not predict this historical sequence; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.25,
              "justification": "If one allows for social/political contestation, retractions can occur even when some underlying risk exists; still below base rate because fraud findings weaken the expectation under H1.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.5,
              "justification": "Spurious early claims corrected later are expected under H2, but K1 reduces trust in the 'retraction implies false' inference; moderately above base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.38,
              "justification": "Rare subgroup effects plus noisy early research could still end in retraction; slightly above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.36,
              "justification": "Similar to H3 under K1; slightly above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.35,
              "justification": "Timing-only theories are not strongly illuminated by this episode; near base rate but slightly above.",
              "relative_to_base_rate": ""
            }
          },
          "K2": {
            "H0": {
              "probability": 0.34,
              "justification": "OTHER remains non-predictive about this episode; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.6,
              "justification": "Under a suppression/censorship paradigm, a prominent pro-link paper later retracted is expected if H1 is true; above base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.3,
              "justification": "If no link exists, K2 considers retraction less diagnostic (could be politicized); thus only slightly below base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.5,
              "justification": "If a subgroup effect exists, K2 still expects pushback/retraction dynamics; above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.48,
              "justification": "Indirect pathways plus perceived suppression makes this episode somewhat expected; above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.45,
              "justification": "Timing/schedule theories can align with temporal narratives that later face institutional rejection; above base rate.",
              "relative_to_base_rate": ""
            }
          }
        },
        "bayesian_metrics_by_paradigm": {
          "K0": {
            "H0": {
              "P(E|H)": 0.34,
              "P(E|~H)": 0.5505,
              "LR": 0.6176,
              "WoE_dB": -2.09,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.12,
              "P(E|~H)": 0.5621,
              "LR": 0.2135,
              "WoE_dB": -6.71,
              "direction": "Moderate Refutation"
            },
            "H2": {
              "P(E|H)": 0.65,
              "P(E|~H)": 0.375,
              "LR": 1.7333,
              "WoE_dB": 2.39,
              "direction": "Weak Support"
            },
            "H3": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.55,
              "LR": 0.8182,
              "WoE_dB": -0.87,
              "direction": "Weak Refutation"
            },
            "H4": {
              "P(E|H)": 0.42,
              "P(E|~H)": 0.5533,
              "LR": 0.759,
              "WoE_dB": -1.2,
              "direction": "Weak Refutation"
            },
            "H5": {
              "P(E|H)": 0.4,
              "P(E|~H)": 0.5556,
              "LR": 0.72,
              "WoE_dB": -1.43,
              "direction": "Weak Refutation"
            }
          },
          "K1": {
            "H0": {
              "P(E|H)": 0.34,
              "P(E|~H)": 0.3361,
              "LR": 1.0116,
              "WoE_dB": 0.05,
              "direction": "Neutral"
            },
            "H1": {
              "P(E|H)": 0.25,
              "P(E|~H)": 0.3831,
              "LR": 0.6526,
              "WoE_dB": -1.85,
              "direction": "Weak Refutation"
            },
            "H2": {
              "P(E|H)": 0.5,
              "P(E|~H)": 0.3183,
              "LR": 1.5707,
              "WoE_dB": 1.96,
              "direction": "Weak Support"
            },
            "H3": {
              "P(E|H)": 0.38,
              "P(E|~H)": 0.3256,
              "LR": 1.167,
              "WoE_dB": 0.67,
              "direction": "Weak Support"
            },
            "H4": {
              "P(E|H)": 0.36,
              "P(E|~H)": 0.3324,
              "LR": 1.0832,
              "WoE_dB": 0.35,
              "direction": "Neutral"
            },
            "H5": {
              "P(E|H)": 0.35,
              "P(E|~H)": 0.335,
              "LR": 1.0448,
              "WoE_dB": 0.19,
              "direction": "Neutral"
            }
          },
          "K2": {
            "H0": {
              "P(E|H)": 0.34,
              "P(E|~H)": 0.4328,
              "LR": 0.7856,
              "WoE_dB": -1.05,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.6,
              "P(E|~H)": 0.4039,
              "LR": 1.4856,
              "WoE_dB": 1.72,
              "direction": "Weak Support"
            },
            "H2": {
              "P(E|H)": 0.3,
              "P(E|~H)": 0.4764,
              "LR": 0.6297,
              "WoE_dB": -2.01,
              "direction": "Weak Refutation"
            },
            "H3": {
              "P(E|H)": 0.5,
              "P(E|~H)": 0.4044,
              "LR": 1.2365,
              "WoE_dB": 0.92,
              "direction": "Weak Support"
            },
            "H4": {
              "P(E|H)": 0.48,
              "P(E|~H)": 0.4135,
              "LR": 1.1607,
              "WoE_dB": 0.65,
              "direction": "Weak Support"
            },
            "H5": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.4188,
              "LR": 1.0744,
              "WoE_dB": 0.31,
              "direction": "Neutral"
            }
          }
        }
      },
      {
        "cluster_id": "C4",
        "cluster_name": "Mechanistic plausibility: immune activation models",
        "description": "Animal/translational evidence that maternal immune activation can produce autism-like phenotypes, suggesting immune-mediated pathways could influence neurodevelopment (not vaccine-specific per se).",
        "evidence_ids": [
          "E5"
        ],
        "cluster_base_rate": 0.45,
        "likelihoods_by_paradigm": {
          "K0": {
            "H0": {
              "probability": 0.45,
              "justification": "OTHER does not predict whether immune-activation animal models exist; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.55,
              "justification": "Direct vaccine-causation hypotheses often invoke immune activation/neuroinflammation mechanisms, so seeing such mechanistic models is somewhat more likely than base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.45,
              "justification": "No-link between vaccines and autism is compatible with immune activation affecting neurodevelopment via infections/other exposures; not a specific vaccine prediction \u2192 set to base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.55,
              "justification": "Subgroup vulnerability hypotheses predict that immune-related susceptibilities could matter; thus mechanistic immune-activation models are somewhat more likely than base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.75,
              "justification": "Indirect pathway via immune activation explicitly predicts mechanistic support for immune-mediated neurodevelopmental disruption; well above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.45,
              "justification": "Schedule-overload is not specifically about maternal immune activation in pregnancy; this evidence is largely orthogonal \u2192 set to base rate.",
              "relative_to_base_rate": ""
            }
          },
          "K1": {
            "H0": {
              "probability": 0.45,
              "justification": "OTHER makes no specific prediction; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.58,
              "justification": "Mechanistic plausibility evidence is treated as more suggestive under K1; somewhat above base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.45,
              "justification": "Still compatible and not specifically predicted by H2; set to base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.6,
              "justification": "Immune-vulnerability framing fits subgroup susceptibility; above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.78,
              "justification": "Immune-activation mechanism is central to H4; above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.48,
              "justification": "Schedule/timing hypotheses weakly connect via immune load ideas; slightly above base rate.",
              "relative_to_base_rate": ""
            }
          },
          "K2": {
            "H0": {
              "probability": 0.45,
              "justification": "OTHER is non-predictive; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.7,
              "justification": "Under K2, immune activation animal models are taken as strong support for vaccine causation narratives; above base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.35,
              "justification": "K2 treats immune-activation evidence as conflicting with 'no vaccine contribution'; thus below base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.68,
              "justification": "K2 expects immune susceptibility to matter for a subgroup; above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.85,
              "justification": "Immune-activation pathway is strongly aligned; well above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.55,
              "justification": "Schedule-overload claims often invoke immune mechanisms; somewhat above base rate.",
              "relative_to_base_rate": ""
            }
          }
        },
        "bayesian_metrics_by_paradigm": {
          "K0": {
            "H0": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.4974,
              "LR": 0.9048,
              "WoE_dB": -0.43,
              "direction": "Neutral"
            },
            "H1": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.4921,
              "LR": 1.1176,
              "WoE_dB": 0.48,
              "direction": "Weak Support"
            },
            "H2": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.5625,
              "LR": 0.8,
              "WoE_dB": -0.97,
              "direction": "Weak Refutation"
            },
            "H3": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.4889,
              "LR": 1.125,
              "WoE_dB": 0.51,
              "direction": "Weak Support"
            },
            "H4": {
              "P(E|H)": 0.75,
              "P(E|~H)": 0.4667,
              "LR": 1.6071,
              "WoE_dB": 2.06,
              "direction": "Weak Support"
            },
            "H5": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.5,
              "LR": 0.9,
              "WoE_dB": -0.46,
              "direction": "Neutral"
            }
          },
          "K1": {
            "H0": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.5922,
              "LR": 0.7598,
              "WoE_dB": -1.19,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.58,
              "P(E|~H)": 0.5769,
              "LR": 1.0053,
              "WoE_dB": 0.02,
              "direction": "Neutral"
            },
            "H2": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.5922,
              "LR": 0.7598,
              "WoE_dB": -1.19,
              "direction": "Weak Refutation"
            },
            "H3": {
              "P(E|H)": 0.6,
              "P(E|~H)": 0.5725,
              "LR": 1.048,
              "WoE_dB": 0.2,
              "direction": "Neutral"
            },
            "H4": {
              "P(E|H)": 0.78,
              "P(E|~H)": 0.5424,
              "LR": 1.4382,
              "WoE_dB": 1.58,
              "direction": "Weak Support"
            },
            "H5": {
              "P(E|H)": 0.48,
              "P(E|~H)": 0.5889,
              "LR": 0.8151,
              "WoE_dB": -0.89,
              "direction": "Weak Refutation"
            }
          },
          "K2": {
            "H0": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.5789,
              "LR": 0.7774,
              "WoE_dB": -1.09,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.7,
              "P(E|~H)": 0.5511,
              "LR": 1.2702,
              "WoE_dB": 1.04,
              "direction": "Weak Support"
            },
            "H2": {
              "P(E|H)": 0.35,
              "P(E|~H)": 0.6586,
              "LR": 0.5315,
              "WoE_dB": -2.75,
              "direction": "Weak Refutation"
            },
            "H3": {
              "P(E|H)": 0.68,
              "P(E|~H)": 0.5375,
              "LR": 1.2651,
              "WoE_dB": 1.02,
              "direction": "Weak Support"
            },
            "H4": {
              "P(E|H)": 0.85,
              "P(E|~H)": 0.5159,
              "LR": 1.6477,
              "WoE_dB": 2.17,
              "direction": "Weak Support"
            },
            "H5": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.5688,
              "LR": 0.9669,
              "WoE_dB": -0.15,
              "direction": "Neutral"
            }
          }
        }
      },
      {
        "cluster_id": "C5",
        "cluster_name": "Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)",
        "description": "Weaker/contested pro-link claims (VAERS-based analyses, subgroup/timing reanalyses), critiques alleging bias in null studies, cross-national schedule correlations, and signals of renewed review/uncertainty; includes some mixed media summaries around schedule.",
        "evidence_ids": [
          "E22",
          "E23",
          "E39",
          "E40",
          "E47",
          "E48",
          "E51",
          "E52"
        ],
        "cluster_base_rate": 0.325,
        "likelihoods_by_paradigm": {
          "K0": {
            "H0": {
              "probability": 0.33,
              "justification": "OTHER does not predict the appearance of a mixed set of contrarian studies/claims and review announcements; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.5,
              "justification": "If vaccines cause autism, one expects at least some positive signals and persistent controversy; thus this cluster is more likely than base rate (even if individual items are low-quality).",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.2,
              "justification": "If there is truly no causal link, some noise/false positives occur, but a concentration of pro-link claims plus policy 'reconsideration' is less likely than base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.45,
              "justification": "Rare-subgroup effects predict occasional subgroup/timing signals and ongoing debate; above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.38,
              "justification": "Indirect immune interactions could yield sporadic and hard-to-replicate signals; slightly above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.48,
              "justification": "Timing/schedule hypotheses predict schedule-intensity correlations and renewed schedule review; above base rate.",
              "relative_to_base_rate": ""
            }
          },
          "K1": {
            "H0": {
              "probability": 0.33,
              "justification": "OTHER remains non-predictive; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.55,
              "justification": "If true harm exists and mainstream methods miss it, K1 expects persistent dissent, bias critiques, and positive signals in alternative analyses; above base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.28,
              "justification": "Even with no link, motivated reasoning and p-hacking can yield contrarian signals; still below base rate but less strongly than K0.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.52,
              "justification": "Subgroup vulnerability fits occasional subgroup findings and ongoing re-analysis; above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.42,
              "justification": "Indirect pathways can be subtle and contested; modestly above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.55,
              "justification": "Schedule/timing concerns predict continued debate, ecological correlations, and institutional reviews; above base rate.",
              "relative_to_base_rate": ""
            }
          },
          "K2": {
            "H0": {
              "probability": 0.33,
              "justification": "OTHER does not predict these specific contested signals; set to base rate exactly.",
              "relative_to_base_rate": ""
            },
            "H1": {
              "probability": 0.75,
              "justification": "Under K2, contrarian signals, VAERS-based associations, subgroup timing effects, and policy reconsiderations are expected manifestations of a real causal relationship; well above base rate.",
              "relative_to_base_rate": ""
            },
            "H2": {
              "probability": 0.15,
              "justification": "If no link exists, K2 views this cluster as comparatively unlikely; below base rate.",
              "relative_to_base_rate": ""
            },
            "H3": {
              "probability": 0.65,
              "justification": "K2 expects subgroup signals and disputes if only some children are vulnerable; above base rate.",
              "relative_to_base_rate": ""
            },
            "H4": {
              "probability": 0.55,
              "justification": "K2 expects immune-mediated controversies and sporadic signals; above base rate.",
              "relative_to_base_rate": ""
            },
            "H5": {
              "probability": 0.7,
              "justification": "K2 expects schedule-intensity associations and renewed schedule scrutiny if timing matters; well above base rate.",
              "relative_to_base_rate": ""
            }
          }
        },
        "bayesian_metrics_by_paradigm": {
          "K0": {
            "H0": {
              "P(E|H)": 0.33,
              "P(E|~H)": 0.2905,
              "LR": 1.1359,
              "WoE_dB": 0.55,
              "direction": "Weak Support"
            },
            "H1": {
              "P(E|H)": 0.5,
              "P(E|~H)": 0.2816,
              "LR": 1.7757,
              "WoE_dB": 2.49,
              "direction": "Weak Support"
            },
            "H2": {
              "P(E|H)": 0.2,
              "P(E|~H)": 0.4313,
              "LR": 0.4638,
              "WoE_dB": -3.34,
              "direction": "Weak Refutation"
            },
            "H3": {
              "P(E|H)": 0.45,
              "P(E|~H)": 0.275,
              "LR": 1.6364,
              "WoE_dB": 2.14,
              "direction": "Weak Support"
            },
            "H4": {
              "P(E|H)": 0.38,
              "P(E|~H)": 0.2828,
              "LR": 1.3438,
              "WoE_dB": 1.28,
              "direction": "Weak Support"
            },
            "H5": {
              "P(E|H)": 0.48,
              "P(E|~H)": 0.2717,
              "LR": 1.7669,
              "WoE_dB": 2.47,
              "direction": "Weak Support"
            }
          },
          "K1": {
            "H0": {
              "P(E|H)": 0.33,
              "P(E|~H)": 0.4917,
              "LR": 0.6712,
              "WoE_dB": -1.73,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.4354,
              "LR": 1.2633,
              "WoE_dB": 1.01,
              "direction": "Weak Support"
            },
            "H2": {
              "P(E|H)": 0.28,
              "P(E|~H)": 0.4972,
              "LR": 0.5631,
              "WoE_dB": -2.49,
              "direction": "Weak Refutation"
            },
            "H3": {
              "P(E|H)": 0.52,
              "P(E|~H)": 0.4644,
              "LR": 1.1198,
              "WoE_dB": 0.49,
              "direction": "Weak Support"
            },
            "H4": {
              "P(E|H)": 0.42,
              "P(E|~H)": 0.4853,
              "LR": 0.8655,
              "WoE_dB": -0.63,
              "direction": "Weak Refutation"
            },
            "H5": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.4672,
              "LR": 1.1772,
              "WoE_dB": 0.71,
              "direction": "Weak Support"
            }
          },
          "K2": {
            "H0": {
              "P(E|H)": 0.33,
              "P(E|~H)": 0.4861,
              "LR": 0.6789,
              "WoE_dB": -1.68,
              "direction": "Weak Refutation"
            },
            "H1": {
              "P(E|H)": 0.75,
              "P(E|~H)": 0.4394,
              "LR": 1.7067,
              "WoE_dB": 2.32,
              "direction": "Weak Support"
            },
            "H2": {
              "P(E|H)": 0.15,
              "P(E|~H)": 0.6079,
              "LR": 0.2468,
              "WoE_dB": -6.08,
              "direction": "Moderate Refutation"
            },
            "H3": {
              "P(E|H)": 0.65,
              "P(E|~H)": 0.4256,
              "LR": 1.5272,
              "WoE_dB": 1.84,
              "direction": "Weak Support"
            },
            "H4": {
              "P(E|H)": 0.55,
              "P(E|~H)": 0.4565,
              "LR": 1.2049,
              "WoE_dB": 0.81,
              "direction": "Weak Support"
            },
            "H5": {
              "P(E|H)": 0.7,
              "P(E|~H)": 0.43,
              "LR": 1.6279,
              "WoE_dB": 2.12,
              "direction": "Weak Support"
            }
          }
        }
      }
    ],
    "visualization": {
      "dot": "/tmp/vaccines_cached_gpt_5_2_8f9bbdf5-evidence-flow.dot",
      "png": "/tmp/vaccines_cached_gpt_5_2_8f9bbdf5-evidence-flow.png",
      "dot_content": "// BFIH Evidence Flow: Do vaccines cause autism in children?...\n// Auto-generated visualization of Bayesian analysis structure\n\ndigraph BFIHEvidenceFlow {\n    // Graph properties\n    rankdir=LR;\n    compound=true;\n    fontname=\"Helvetica-Bold,Arial Bold,sans-serif\";\n    node [fontname=\"Helvetica,Arial,sans-serif\", fontsize=10];\n    edge [fontname=\"Helvetica,Arial,sans-serif\", fontsize=8];\n    label=\"BFIH Analysis of Proposition:\\n\\\"Do vaccines cause autism in children?\\\"\";\n    labelloc=\"t\";\n    fontsize=18;\n\n    // ============================================================\n    // Hypothesis Space\n    // ============================================================\n\n    subgraph cluster_hypotheses {\n        label=\"Hypothesis Space (6 explanations)\";\n        style=\"filled,rounded\";\n        fillcolor=\"#E8F4F8\";\n        fontsize=12;\n        penwidth=2;\n\n        h0 [label=\"H0: OTHER - Unforeseen explanation\\n\\nPrior: 0.05\\nPosterior: 0.019\\nStatus: WEAK\",\n            shape=box, style=\"filled,rounded\", fillcolor=\"#E0E0E0\", penwidth=1];\n\n        h1 [label=\"H1: TRUE - Vaccines directly cause\\nautism\\n\\nPrior: 0.05\\nPosterior: 0.001\\nStatus: WEAK\",\n            shape=box, style=\"filled,rounded\", fillcolor=\"#CCFFCC\", penwidth=1];\n\n        h2 [label=\"H2: FALSE - No causal link exists\\n\\nPrior: 0.60\\nPosterior: 0.727\\nStatus: STRONGEST\",\n            shape=box, style=\"filled,rounded\", fillcolor=\"#FF9999\", penwidth=3];\n\n        h3 [label=\"H3: PARTIAL - Rare subgroup\\nvulnerability\\n\\nPrior: 0.10\\nPosterior: 0.097\\nStatus: STRONG\",\n            shape=box, style=\"filled,rounded\", fillcolor=\"#B3D9FF\", penwidth=2.5];\n\n        h4 [label=\"H4: PARTIAL - Indirect pathway via\\nimmune activation\\n\\nPrior: 0.10\\nPosterior: 0.094\\nStatus: WEAK\",\n            shape=box, style=\"filled,rounded\", fillcolor=\"#B3D9FF\", penwidth=1];\n\n        h5 [label=\"H5: PARTIAL - Timing/schedule effects\\nonly\\n\\nPrior: 0.10\\nPosterior: 0.062\\nStatus: WEAK\",\n            shape=box, style=\"filled,rounded\", fillcolor=\"#B3D9FF\", penwidth=1];\n\n    }\n\n    // ============================================================\n    // Evidence Clusters\n    // ============================================================\n\n    subgraph cluster_c1 {\n        label=\"C1: Large epidemiology & meta-analyses\\n(mostly null associations)\\n(25 items)\";\n        style=\"filled,rounded\";\n        fillcolor=\"#FFE6E6\";\n        fontsize=10;\n\n        c1_node [label=\"Large cohort/case-control studies\\nand meta-analyses examining MMR,\\nthimerosal/ethylmercury, antigen\\n(25 items)\\n\\nWoE to H2: 2.2 dB\",\n                 shape=ellipse, style=\"filled\", fillcolor=\"#FFCCCC\"];\n    }\n\n    subgraph cluster_c2 {\n        label=\"C2: Institutional consensus & authoritative\\nreviews\\n(13 items)\";\n        style=\"filled,rounded\";\n        fillcolor=\"#FFFCE6\";\n        fontsize=10;\n\n        c2_node [label=\"Consensus statements and major\\nreviews (IOM/NASEM, CDC, AAP, WHO,\\nBrookings expert commentary, and\\n(13 items)\\n\\nWoE to H2: 2.8 dB\",\n                 shape=ellipse, style=\"filled\", fillcolor=\"#FFFFCC\"];\n    }\n\n    subgraph cluster_c3 {\n        label=\"C3: Wakefield episode: initial signal, then\\nretraction/fraud analysis\\n(5 items)\";\n        style=\"filled,rounded\";\n        fillcolor=\"#FFF0E6\";\n        fontsize=10;\n\n        c3_node [label=\"The original small 1998 case\\nseries suggesting a temporal\\nassociation, followed by formal\\n(5 items)\\n\\nWoE to H2: 2.4 dB\",\n                 shape=ellipse, style=\"filled\", fillcolor=\"#FFE6CC\"];\n    }\n\n    subgraph cluster_c4 {\n        label=\"C4: Mechanistic plausibility: immune\\nactivation models\\n(1 items)\";\n        style=\"filled,rounded\";\n        fillcolor=\"#E6F3FF\";\n        fontsize=10;\n\n        c4_node [label=\"Animal/translational evidence that\\nmaternal immune activation can\\nproduce autism-like phenotypes,\\n(1 items)\\n\\nWoE to H4: 2.1 dB\",\n                 shape=ellipse, style=\"filled\", fillcolor=\"#CCE6FF\"];\n    }\n\n    subgraph cluster_c5 {\n        label=\"C5: Contrarian/contested evidence & ongoing\\nreviews (VAERS/ecological signals,\\npreprints, subgroup/timing claims,\\npolicy noise)\\n(8 items)\";\n        style=\"filled,rounded\";\n        fillcolor=\"#F0E6FF\";\n        fontsize=10;\n\n        c5_node [label=\"Weaker/contested pro-link claims\\n(VAERS-based analyses,\\nsubgroup/timing reanalyses),\\ncritiques\\n(8 items)\\n\\nWoE to H1: 2.5 dB\",\n                 shape=ellipse, style=\"filled\", fillcolor=\"#E6CCFF\"];\n    }\n\n    // ============================================================\n    // Evidence flows to hypotheses\n    // ============================================================\n\n    c1_node -> h1 [label=\"LR: 0.16\", color=\"#CC0000\", penwidth=1.5, style=dotted];\n    c1_node -> h2 [label=\"LR: 1.65\", color=\"#66CC66\", penwidth=2, style=solid];\n    c2_node -> h1 [label=\"LR: 0.24\", color=\"#CC0000\", penwidth=1.5, style=dotted];\n    c2_node -> h2 [label=\"LR: 1.91\", color=\"#66CC66\", penwidth=2, style=solid];\n    c3_node -> h1 [label=\"LR: 0.21\", color=\"#CC0000\", penwidth=1.5, style=dotted];\n    c3_node -> h2 [label=\"LR: 1.73\", color=\"#66CC66\", penwidth=2, style=solid];\n    c4_node -> h2 [label=\"LR: 0.80\", color=\"#CC6666\", penwidth=1, style=dotted];\n    c4_node -> h4 [label=\"LR: 1.61\", color=\"#66CC66\", penwidth=2, style=solid];\n    c5_node -> h1 [label=\"LR: 1.78\", color=\"#66CC66\", penwidth=2, style=solid];\n    c5_node -> h2 [label=\"LR: 0.46\", color=\"#CC0000\", penwidth=1.5, style=dotted];\n\n    // ============================================================\n    // Posterior Summary\n    // ============================================================\n\n    posterior_summary [label=\"K0 Posteriors\\n\\nH2: 72.7%\\nH3: 9.7%\\nH4: 9.4%\\nH5: 6.2%\\nH0: 1.9%\\n\\nVerdict: STRONGLY SUPPORTED\",\n                        shape=box, style=\"filled,rounded\", fillcolor=\"#FFF4E6\",\n                        fontsize=11, penwidth=2];\n\n    h0 -> posterior_summary [style=dashed];\n    h1 -> posterior_summary [style=dashed];\n    h2 -> posterior_summary [style=solid];\n    h3 -> posterior_summary [style=dashed];\n    h4 -> posterior_summary [style=dashed];\n    h5 -> posterior_summary [style=dashed];\n\n    // ============================================================\n    // Paradigm Comparison\n    // ============================================================\n\n    subgraph cluster_paradigm_compare {\n        label=\"Cross-Paradigm Comparison\";\n        style=\"filled,rounded\";\n        fillcolor=\"#F0E6FF\";\n        fontsize=11;\n\n        paradigm_k0 [label=\"K0: Scientific Cons\\nH2: 72.7%\", style=\"filled\", fillcolor=\"#E6CCFF\"];\n        paradigm_k1 [label=\"K1: Vaccine Skeptic\\nH3: 31.0%\", style=\"filled\", fillcolor=\"#E6CCFF\"];\n        paradigm_k2 [label=\"K2: Precautionary\\nH3: 31.2%\", style=\"filled\", fillcolor=\"#E6CCFF\"];\n    }\n\n    posterior_summary -> paradigm_k0 [style=solid];\n    posterior_summary -> paradigm_k1 [style=dashed];\n    posterior_summary -> paradigm_k2 [style=dashed];\n\n    // ============================================================\n    // Evidence Base Assessment\n    // ============================================================\n\n    evidence_assessment [label=\"Evidence Assessment\\n\\nTotal Evidence Items: 52\\nEvidence Clusters: 5\\nParadigms Analyzed: 3\\nAvg Items/Cluster: 10.4\\n\\nCoverage: Extensive\",\n                          shape=box, style=\"filled,rounded\", fillcolor=\"#E6FFE6\",\n                          fontsize=10, penwidth=1.5];\n\n    // ============================================================\n    // Bayesian Synthesis\n    // ============================================================\n\n    bayesian_synthesis [label=\"BAYESIAN SYNTHESIS\\n\\nH2: 60% \u2192 72.7% (+12.7%)\\nH3: 10% \u2192 9.7% (-0.3%)\\nH4: 10% \u2192 9.4% (-0.6%)\\n\\nTotal WoE: 62.1 dB\",\n                         shape=box, style=\"filled,rounded\", fillcolor=\"#E6F3FF\",\n                         fontsize=10, penwidth=1.5];\n\n    paradigm_k0 -> bayesian_synthesis [style=dashed, color=\"#666666\"];\n    paradigm_k1 -> bayesian_synthesis [style=dashed, color=\"#666666\"];\n    paradigm_k2 -> bayesian_synthesis [style=dashed, color=\"#666666\"];\n\n    // ============================================================\n    // Key Insights\n    // ============================================================\n\n    key_insights [label=\"KEY INSIGHTS\\n\\n\u2022 2 different conclusions across paradigms\\n\u2022 0 strong support signals\\n\u2022 3 strong refutation signals\\n\u2022 Decisive margin (63%) over alternatives\",\n                   shape=box, style=\"filled,rounded\", fillcolor=\"#FFF0F5\",\n                   fontsize=10, penwidth=1.5];\n\n    bayesian_synthesis -> key_insights [style=solid];\n\n    // ============================================================\n    // Final Analysis Summary\n    // ============================================================\n\n    final_summary [label=\"ANALYSIS CONCLUSION\\n\\nLeading Hypothesis: H2\\n(FALSE - No causal link exists)\\n\\nPosterior: 72.7%\\nMargin over #2: 63.0%\\nConfidence: High\\n\\nStatus: STRONGLY SUPPORTED\",\n                    shape=box, style=\"filled,bold,rounded\", fillcolor=\"#FFE4B5\",\n                    fontsize=11, penwidth=3];\n\n    key_insights -> final_summary [style=solid, penwidth=2];\n\n}"
    }
  },
  "created_at": "2026-01-19T13:41:24.283318+00:00",
  "scenario_config": {
    "proposition": "Do vaccines cause autism in children?",
    "domain": "medicine",
    "difficulty": "hard",
    "paradigms": [
      {
        "id": "K0",
        "name": "Scientific Consensus",
        "description": "Mainstream scientific and medical consensus based on epidemiological evidence, meta-analyses, and mechanistic biology.",
        "ontology": "Material, measurable biological processes",
        "epistemology": "Empirical observation, RCTs, systematic reviews, falsification",
        "axiology": "Public health, harm reduction, evidence-based medicine"
      },
      {
        "id": "K1",
        "name": "Vaccine Skeptic",
        "description": "Perspective that questions vaccine safety claims, emphasizes anecdotal reports, and distrusts pharmaceutical/regulatory institutions.",
        "ontology": "Individual experiences and observable outcomes",
        "epistemology": "Personal testimony, pattern recognition in adverse event reports",
        "axiology": "Parental autonomy, precaution, distrust of authority"
      },
      {
        "id": "K2",
        "name": "Precautionary",
        "description": "Accepts most vaccine science but emphasizes unknown long-term risks and subgroup vulnerabilities.",
        "ontology": "Complex systems with emergent effects",
        "epistemology": "Scenario modeling, acknowledging uncertainty",
        "axiology": "Precautionary principle, intergenerational responsibility"
      }
    ],
    "hypotheses": [
      {
        "id": "H0",
        "name": "OTHER - Unforeseen explanation",
        "short_name": "Unforeseen",
        "description": "Some unknown factor not captured by the other hypotheses explains the relationship (or lack thereof) between vaccines and autism.",
        "verdict_type": "OTHER"
      },
      {
        "id": "H1",
        "name": "TRUE - Vaccines directly cause autism",
        "short_name": "Direct Causation",
        "description": "Vaccines (or their components like thimerosal, aluminum adjuvants, or antigens) directly cause autism through biological mechanisms such as immune activation, neurotoxicity, or gut-brain axis disruption.",
        "verdict_type": "TRUE"
      },
      {
        "id": "H2",
        "name": "FALSE - No causal link exists",
        "short_name": "No Causation",
        "description": "There is no causal relationship between vaccines and autism. The temporal correlation (vaccines given around age when autism symptoms appear) is coincidental. Large epidemiological studies consistently show no increased risk.",
        "verdict_type": "FALSE"
      },
      {
        "id": "H3",
        "name": "PARTIAL - Rare subgroup vulnerability",
        "short_name": "Subgroup Effect",
        "description": "While vaccines don't cause autism in the general population, a small subset of genetically or immunologically vulnerable children may experience adverse neurodevelopmental effects. This subgroup is too small to detect in population studies.",
        "verdict_type": "PARTIAL"
      },
      {
        "id": "H4",
        "name": "PARTIAL - Indirect pathway via immune activation",
        "short_name": "Indirect Pathway",
        "description": "Vaccines don't directly cause autism, but in rare cases, the immune response they trigger may interact with pre-existing conditions to affect neurodevelopment. The effect is real but indirect and context-dependent.",
        "verdict_type": "PARTIAL"
      },
      {
        "id": "H5",
        "name": "PARTIAL - Timing/schedule effects only",
        "short_name": "Timing Effects",
        "description": "Individual vaccines are safe, but the cumulative effect of the vaccination schedule (multiple vaccines in short timeframes) may overwhelm some children's immune systems, contributing to developmental issues in susceptible individuals.",
        "verdict_type": "PARTIAL"
      }
    ],
    "priors_by_paradigm": {
      "K0": {
        "H0": 0.05,
        "H1": 0.05,
        "H2": 0.6,
        "H3": 0.1,
        "H4": 0.1,
        "H5": 0.1
      },
      "K1": {
        "H0": 0.1,
        "H1": 0.35,
        "H2": 0.1,
        "H3": 0.2,
        "H4": 0.15,
        "H5": 0.1
      },
      "K2": {
        "H0": 0.1,
        "H1": 0.1,
        "H2": 0.3,
        "H3": 0.2,
        "H4": 0.15,
        "H5": 0.15
      }
    },
    "evidence": {
      "items": [
        {
          "evidence_id": "E1",
          "description": "In a retrospective cohort study of 537,303 children born in Denmark from January 1991 through December 1998, the relative risk of autistic disorder among children who received the MMR vaccine compared with unvaccinated children was 0.92 (95% CI, 0.68\u20131.24), and for other autistic-spectrum disorders was 0.83 (95% CI, 0.65\u20131.07). No association was observed between age at vaccination, time since vaccination, or date of vaccination and development of autistic disorder.",
          "source_name": "New England Journal of Medicine",
          "source_url": "https://www.nejm.org/doi/full/10.1056/NEJMoa021134",
          "citation_apa": "Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., & Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJMoa021134",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E2",
          "description": "The Institute of Medicine\u2019s 2004 consensus report reviewed published and unpublished epidemiological studies and potential biological mechanisms and concluded that the body of epidemiological evidence favors rejection of a causal relationship between MMR and thimerosal-containing vaccines and autism, finding only theoretical support for any biologic mechanism.",
          "source_name": "National Academies Press",
          "source_url": "https://nap.nationalacademies.org/catalog/10997/immunization-safety-review-vaccines-and-autism",
          "citation_apa": "Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. https://doi.org/10.17226/10997",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H4",
            "H5"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E3",
          "description": "A CDC-led case-control study of 256 children with ASD and 752 controls across three managed care organizations found that prenatal and infant exposure to thimerosal from vaccines and immunoglobulins was not associated with any increase in risk for autism spectrum disorder or its subtypes.",
          "source_name": "Centers for Disease Control and Prevention",
          "source_url": "https://archive.cdc.gov/www_cdc_gov/vaccinesafety/concerns/thimerosal/study-risk-autism.html",
          "citation_apa": "Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L. A., Hinrichsen, V. L., Marcy, M., Robertson, A., Erisken, E., Lewis, E., Bernal, P., Shay, D., Davis, R. L., & DeStefano, F. (2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656\u2013664. https://doi.org/10.1542/peds.2010-0309",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E4",
          "description": "A 2014 evidence-based meta-analysis of five cohort studies (1,256,407 children) and five case-control studies (9,920 children) reported no relationship between vaccination and autism (OR 0.99; 95% CI, 0.92\u20131.06), ASD (OR 0.91; 95% CI, 0.68\u20131.20), MMR (OR 0.84; 95% CI, 0.70\u20131.01), thimerosal (OR 1.00; 95% CI, 0.77\u20131.31), or mercury (OR 1.00; 95% CI, 0.93\u20131.07).",
          "source_name": "Vaccine",
          "source_url": "https://doi.org/10.1016/j.vaccine.2014.04.085",
          "citation_apa": "Taylor, L. E., Swerdfeger, A. L., & Eslick, G. D. (2014). Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies. Vaccine, 32(29), 3623\u20133629. https://doi.org/10.1016/j.vaccine.2014.04.085",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E5",
          "description": "Animal and translational studies reviewed by Patterson (2011) demonstrate that maternal immune activation during pregnancy induces offspring with behavioral and neuropathological features resembling autism, implicating interleukin-6\u2013mediated immune pathways in fetal brain development.",
          "source_name": "Trends in Molecular Medicine",
          "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3135697/",
          "citation_apa": "Patterson, P. H. (2011). Maternal infection and immune involvement in autism. Trends in Molecular Medicine, 17(7), 389\u2013394. https://doi.org/10.1016/j.molmed.2011.03.001",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H4"
          ],
          "refutes_hypotheses": [],
          "evidence_type": "qualitative"
        },
        {
          "evidence_id": "E6",
          "description": "In a population-based case-control study in metropolitan Atlanta of 625 children with autism and 1,824 matched controls, no significant difference was found in age at first MMR vaccination: 70.5% of cases and 67.5% of controls were vaccinated between 12 and 17 months, with no association observed at other age cutoffs.",
          "source_name": "Pediatrics",
          "source_url": "https://www.immunizationinfo.org/science/autism-and-age-first-mmr-vaccination/",
          "citation_apa": "DeStefano, F., Bhasin, B. K., Thompson, W. W., Yeargin-Allsopp, M., & Boyle, C. (2004). Age at first Measles-Mumps-Rubella vaccination in children with autism and school-matched control subjects: A population-based study in metropolitan Atlanta. Pediatrics, 113(2), 259\u2013266. https://doi.org/10.1542/peds.113.2.259",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E7",
          "description": "On February 2, 2010, editors of The Lancet fully retracted the 1998 Wakefield et al. paper linking MMR vaccination to autism, stating that key elements of the study were incorrect and that the lead author had been dishonest and unethical.",
          "source_name": "BMJ",
          "source_url": "https://www.bmj.com/content/340/bmj.c696",
          "citation_apa": "Dyer, C. (2010). Lancet retracts Wakefield\u2019s MMR paper. BMJ, 340, c696. https://doi.org/10.1136/bmj.c696",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H0"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "historical_analogy"
        },
        {
          "evidence_id": "E8",
          "description": "The CDC\u2019s MMR vaccine safety page states that multiple carefully performed studies\u2014including IOM (2004) reviews and ongoing surveillance\u2014have found no link between MMR vaccination and autism, and that signs of ASD appearing around vaccine administration reflect coincidence in timing.",
          "source_name": "Centers for Disease Control and Prevention",
          "source_url": "https://www.cdc.gov/vaccine-safety/vaccines/mmr.html",
          "citation_apa": "Centers for Disease Control and Prevention. (2025). MMR Vaccine Safety. Retrieved January 19, 2026, from https://www.cdc.gov/vaccine-safety/vaccines/mmr.html",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E9",
          "description": "A 2012 Cochrane systematic review of 64 studies evaluating MMR (and MMRV) vaccines in children up to age 15 found no evidence of an increased risk of autism following vaccination.",
          "source_name": "Cochrane Database of Systematic Reviews",
          "source_url": "https://doi.org/10.1002/14651858.CD004407.pub3",
          "citation_apa": "Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012). Vaccines for measles, mumps and rubella in children. Cochrane Database of Systematic Reviews, (2), CD004407. https://doi.org/10.1002/14651858.CD004407.pub3",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E10",
          "description": "In a population-based cohort study of 467,450 Danish children born between January 1, 1990, and December 31, 1996, comparing those who received thimerosal-containing pertussis vaccines to those who received thimerosal-free formulations, the rate ratio (RR) for autism among exposed children was 0.85 (95% CI, 0.60\u20131.20), with no dose-response trend observed per 25 \u00b5g ethylmercury (RR 0.98; 95% CI, 0.90\u20131.06).",
          "source_name": "JAMA",
          "source_url": "https://jamanetwork.com/journals/jama/fullarticle/197365",
          "citation_apa": "Hviid, A., Stellfeld, M., Wohlfahrt, J., & Melbye, M. (2003). Association between thimerosal-containing vaccine and autism. JAMA, 290(13), 1763\u20131766.",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E11",
          "description": "The Institute of Medicine's 2004 Immunization Safety Review concluded, after reviewing over 200 studies, that neither the MMR vaccine nor thimerosal-containing vaccines are associated with autism and that proposed biological mechanisms remain theoretical without empirical support.",
          "source_name": "National Academies Press",
          "source_url": "https://nap.nationalacademies.org/read/10997/chapter/3",
          "citation_apa": "Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. doi:10.17226/10997",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E12",
          "description": "The American Academy of Pediatrics' fact-checked resource affirms that rigorous research spanning decades has found no credible link between vaccines and autism, noting the retraction of fraudulent studies and emphasizing ongoing review of vaccine safety data.",
          "source_name": "American Academy of Pediatrics",
          "source_url": "https://www.aap.org/en/news-room/fact-checked/fact-checked-vaccines-safe-and-effect-no-link-to-autism/",
          "citation_apa": "American Academy of Pediatrics. (2025). Fact Checked: Vaccines: Safe and Effective, No Link to Autism. Retrieved January 19, 2026, from https://www.aap.org/en/news-room/fact-checked/fact-checked-vaccines-safe-and-effect-no-link-to-autism/",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E13",
          "description": "The World Health Organization's Global Advisory Committee on Vaccine Safety reaffirmed in 2025, after reviewing 31 studies from 2010\u20132025, that there is no causal link between childhood vaccines (including those with thiomersal or aluminum adjuvants) and autism spectrum disorder, deeming outlier studies methodologically flawed.",
          "source_name": "People.com",
          "source_url": "https://people.com/world-health-organization-who-says-childhood-vaccines-do-not-cause-autism-no-link-asd-11868287",
          "citation_apa": "People.com. (2025). WHO Reaffirms That 'Childhood Vaccines Do Not Cause Autism' After Reviewing Latest Research. Retrieved January 19, 2026, from https://people.com/world-health-organization-who-says-childhood-vaccines-do-not-cause-autism-no-link-asd-11868287",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E14",
          "description": "A correspondence in Molecular Psychiatry reported consistent epidemiological failure to find any association between MMR vaccination and autistic enterocolitis in multiple studies, reinforcing the absence of a vaccine-related gastrointestinal trigger for autism.",
          "source_name": "Molecular Psychiatry",
          "source_url": "https://doi.org/10.1038/sj.mp.4001266",
          "citation_apa": "Fombonne, E., & Cook, E. (2003). MMR and autistic enterocolitis: Consistent epidemiological failure to find an association. Molecular Psychiatry, 8(2), 133\u2013134.",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E15",
          "description": "The Lancet retracted the 1998 Wakefield et al. paper linking MMR vaccination to autism in February 2010 after an investigation found data fabrication, unethical procedures, and undeclared conflicts of interest, discrediting the original hypothesis of a vaccine-induced autism mechanism.",
          "source_name": "The Guardian",
          "source_url": "https://www.theguardian.com/society/2010/feb/02/lancet-retracts-mmr-paper",
          "citation_apa": "Boseley, S. (2010, February 2). Lancet retracts 'utterly false' MMR paper. The Guardian. Retrieved January 19, 2026, from https://www.theguardian.com/society/2010/feb/02/lancet-retracts-mmr-paper",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "historical_analogy"
        },
        {
          "evidence_id": "E16",
          "description": "A 1998 case series in The Lancet described 12 children with ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder, suggesting a temporal association between measles-containing vaccines and onset of autism symptoms.",
          "source_name": "The Lancet",
          "source_url": "https://doi.org/10.1016/S0140-6736(97)11096-0",
          "citation_apa": "Wakefield MR, et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637\u2013641. https://doi.org/10.1016/S0140-6736(97)11096-0",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H1"
          ],
          "refutes_hypotheses": [
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E17",
          "description": "A population-based cohort study of 537,303 Danish children found no increased risk of autism among children who received the MMR vaccine compared to unvaccinated children.",
          "source_name": "New England Journal of Medicine",
          "source_url": "https://www.nejm.org/doi/full/10.1056/NEJM200211143471901",
          "citation_apa": "Madsen KM, et al. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477\u20131482. https://doi.org/10.1056/NEJM200211143471901",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E18",
          "description": "A UK case-control study of 1,397 children found no epidemiologic evidence linking MMR vaccination to autism.",
          "source_name": "BMJ",
          "source_url": "https://www.bmj.com/content/321/7269/1029",
          "citation_apa": "Taylor B, et al. (1999). Autism and measles, mumps, and rubella vaccine: No epidemiologic evidence for a causal association. BMJ, 321(7269), 1029\u20131033. https://doi.org/10.1136/bmj.321.7269.1029",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E19",
          "description": "A nationwide Danish cohort of 657,461 children born 1999\u20132010 showed no increased hazard of autism following MMR vaccination, including in subgroups at higher genetic risk.",
          "source_name": "Annals of Internal Medicine",
          "source_url": "https://doi.org/10.7326/M18-2101",
          "citation_apa": "Hviid A, Hansen JV, Frisch M, Melbye M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513\u2013520. https://doi.org/10.7326/M18-2101",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E20",
          "description": "In a cohort of children, total antigens from vaccines received up to age 2 and maximum antigens in a single visit were not associated with neuropsychological outcomes or ASD diagnosis at age 7\u201310 years.",
          "source_name": "Pharmacoepidemiology and Drug Safety",
          "source_url": "https://doi.org/10.1002/pds.3482",
          "citation_apa": "Iqbal S, Barile JP, Thompson WW, DeStefano F. (2013). Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7\u201310 years. Pharmacoepidemiology and Drug Safety, 22(12), 1263\u20131270. https://doi.org/10.1002/pds.3482",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E21",
          "description": "The 2004 Institute of Medicine review concluded that epidemiological evidence favors rejection of a causal relationship between thimerosal-containing vaccines or MMR vaccination and autism, finding biological mechanisms theoretical only.",
          "source_name": "National Academies Press",
          "source_url": "https://doi.org/10.17226/10997",
          "citation_apa": "Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. https://doi.org/10.17226/10997",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E22",
          "description": "A 2025 preprint critique of Hviid et al.\u2019s 2019 cohort study argued that healthy-user bias among unvaccinated children could mask a true association between MMR vaccination and autism.",
          "source_name": "Preprints.org",
          "source_url": "https://www.preprints.org/manuscript/202501.0796/v2",
          "citation_apa": "Preprints.org. (2025). Hviid et al. 2019 Vaccine-Autism Study: Much Ado About Nothing? v2. https://doi.org/10.20944/preprints202501.0796.v2",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H0"
          ],
          "refutes_hypotheses": [
            "H2"
          ],
          "evidence_type": "qualitative"
        },
        {
          "evidence_id": "E23",
          "description": "A November 2025 CDC webpage update stated that studies have not definitively ruled out infant vaccines as a contributor to autism, reversing prior consensus that vaccines do not cause autism.",
          "source_name": "Centers for Disease Control and Prevention",
          "source_url": "https://beta.cdc.gov/vaccine-safety/about/autism.html",
          "citation_apa": "Centers for Disease Control and Prevention. (2025, November 19). Autism and Vaccines. U.S. Department of Health and Human Services. https://beta.cdc.gov/vaccine-safety/about/autism.html",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H1"
          ],
          "refutes_hypotheses": [
            "H2"
          ],
          "evidence_type": "policy"
        },
        {
          "evidence_id": "E24",
          "description": "A cohort of 196,929 children showed no significant association between maternal influenza vaccination during any trimester and ASD risk in offspring after adjustment for multiple comparisons.",
          "source_name": "JAMA Pediatrics",
          "source_url": "https://doi.org/10.1001/jamapediatrics.2016.3609",
          "citation_apa": "Zerbo O, et al. (2017). Association between influenza infection and vaccination during pregnancy and risk of autism spectrum disorder. JAMA Pediatrics, 171(1), e163609. https://doi.org/10.1001/jamapediatrics.2016.3609",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H4"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E25",
          "description": "An Institute of Medicine committee reviewed over 1,000 articles and found no or insufficient evidence to support a causal relationship between MMR vaccination and autism, concluding \u201cthe MMR vaccine does not cause autism.\u201d",
          "source_name": "HealthLeaders Media",
          "source_url": "https://www.healthleadersmedia.com/clinical-care/mmr-vaccine-does-not-cause-autism-says-iom",
          "citation_apa": "Clark, C. (2011, August 26). MMR Vaccine Does Not Cause Autism, Says IOM. HealthLeaders Media.",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E26",
          "description": "Ecological analysis of Danish registers (1971\u20132000) showed autism incidence continued to rise after the removal of thimerosal from vaccines in 1992, with no correlation between thimerosal exposure levels (0\u2013400 \u00b5g Hg) and autism risk (p=0.40).",
          "source_name": "Pediatrics",
          "source_url": "https://pure.au.dk/portal/en/publications/thimerosal-and-the-occurrence-of-autism-negative-ecological-evide",
          "citation_apa": "Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., & Plesner, A.-M. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. doi:10.1542/peds.112.3.Part1.604",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H4"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E27",
          "description": "In a US retrospective cohort of 95,727 children with older siblings, MMR vaccination was not associated with increased ASD risk at age 2 (RR 0.76; 95% CI 0.49\u20131.18) or age 5 (RR 0.56; 95% CI 0.31\u20131.01) among high-risk children, indicating no subgroup vulnerability.",
          "source_name": "JAMA",
          "source_url": "https://jamanetwork.com/journals/jama/fullarticle/2275444",
          "citation_apa": "Jain, A., Marshall, J., Buikema, A., Bancroft, T., Kelly, J. P., & Newschaffer, C. J. (2015). Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA, 313(15), 1534\u20131540. doi:10.1001/jama.2015.3077",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H3"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E28",
          "description": "Case-control study of 256 ASD and 752 control children found no association between cumulative or maximum daily antigen exposure from vaccines in the first two years and ASD risk, despite antigen loads decreasing from thousands to 315 over decades.",
          "source_name": "The Journal of Pediatrics",
          "source_url": "https://www.sciencedaily.com/releases/2013/03/130329090310.htm",
          "citation_apa": "DeStefano, F., Price, C. S., & Weintraub, E. (2013). Risk of autism is not increased by 'too many vaccines too soon,' study shows. The Journal of Pediatrics, 163(1), 79\u201385. doi:10.1016/j.jpeds.2013.01.029",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E29",
          "description": "In a Danish cohort of 537,303 children, MMR-vaccinated children (n=440,655) had an adjusted relative risk (RR) of autism of 0.92 (95% CI, 0.68\u20131.24) and ASD of 0.83 (95% CI, 0.65\u20131.07), indicating no increased risk of autism following MMR vaccination.",
          "source_name": "New England Journal of Medicine",
          "source_url": "https://doi.org/10.1056/NEJMoa021134",
          "citation_apa": "Madsen, K. M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., & Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19), 1477-1482. https://doi.org/10.1056/NEJMoa021134",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E30",
          "description": "After discontinuation of thimerosal-containing vaccines in Denmark in 1992, the incidence of autism continued to rise from 1991 to 2000 among children aged 2\u201310 years, with no decline in autism rates following thimerosal removal.",
          "source_name": "Pediatrics",
          "source_url": "https://pubmed.ncbi.nlm.nih.gov/12949291/",
          "citation_apa": "Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., & Mortensen, P. B. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604-606. https://doi.org/10.1542/peds.112.3.604",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E31",
          "description": "An updated Cochrane review of MMR, MMRV, and MMR+V vaccines found no evidence of increased autism risk and confirmed vaccine effectiveness, with moderate-to-high certainty across studies up to May 2019.",
          "source_name": "Cochrane Database of Systematic Reviews",
          "source_url": "https://www.cochrane.org/CD004407/VACCINES_measles-mumps-rubella-varicella-vaccines-children",
          "citation_apa": "Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2019). Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews, 2019(4), CD004407. https://doi.org/10.1002/14651858.CD004407.pub2",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E32",
          "description": "In a case-control study of 256 ASD cases and 752 controls, increasing cumulative exposure to vaccine antigens up to age 2 years showed no association with ASD risk (aOR per 25-unit antigen increase ranged from 0.999 to 1.001).",
          "source_name": "The Journal of Pediatrics",
          "source_url": "https://pubmed.ncbi.nlm.nih.gov/23545349/",
          "citation_apa": "DeStefano, F., Price, C. S., & Weintraub, E. S. (2013). Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. Journal of Pediatrics, 163(2), 561-567. https://doi.org/10.1016/j.jpeds.2013.02.001",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E33",
          "description": "CDC states that extensive studies have found no link between receiving vaccines and developing ASD, and that no vaccine ingredients have been associated with increased autism risk.",
          "source_name": "Centers for Disease Control and Prevention",
          "source_url": "https://www.cdc.gov/vaccine-safety/about/autism.html",
          "citation_apa": "Centers for Disease Control and Prevention. (2024, December 30). Autism and vaccines. CDC. Retrieved January 19, 2026, from https://www.cdc.gov/vaccine-safety/about/autism.html",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E34",
          "description": "The Institute of Medicine\u2019s 2011 report reviewed over 1,000 studies of eight vaccines and concluded there is no causal relationship between vaccination and autism, stating the evidence favors rejection of any causal link.",
          "source_name": "National Academies Press",
          "source_url": "https://doi.org/10.17226/13164",
          "citation_apa": "Institute of Medicine. (2011). Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: National Academies Press. https://doi.org/10.17226/13164",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E35",
          "description": "The Editors of The Lancet formally retracted the 1998 Wakefield et al. paper in February 2010 after the UK General Medical Council found data falsification and unethical procedures, invalidating the initial suggestion of an MMR-autism link.",
          "source_name": "The Lancet",
          "source_url": "https://doi.org/10.1016/S0140-6736(10)60175-7",
          "citation_apa": "The Editors of The Lancet. (2010). Retraction\u2014Ileal-lymphoid-nodular hyperplasia, non\u2010specific colitis, and pervasive developmental disorder in children. The Lancet. https://doi.org/10.1016/S0140-6736(10)60175-7",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E36",
          "description": "The WHO Global Advisory Committee on Vaccine Safety\u2019s December 2025 review of 31 primary studies (2010\u20132025) and meta-analyses reaffirmed that vaccines, including those with thiomersal or aluminum adjuvants, do not cause ASD.",
          "source_name": "World Health Organization",
          "source_url": "https://www.who.int/news/item/11-12-2025-who-expert-group-s-new-analysis-reaffirms-there-is-no-link-between-vaccines-and-autism",
          "citation_apa": "World Health Organization. (2025, December 11). WHO expert group\u2019s new analysis reaffirms there is no link between vaccines and autism. Retrieved January 19, 2026, from https://www.who.int/news/item/11-12-2025-who-expert-group-s-new-analysis-reaffirms-there-is-no-link-between-vaccines-and-autism",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E37",
          "description": "A systematic review of 67 studies on routine pediatric vaccines in the United States found high-strength evidence that the MMR vaccine is not associated with autism, and moderate evidence of rare adverse events (e.g., intussusception with rotavirus vaccine), underscoring the overall safety of the immunization schedule.",
          "source_name": "Pediatrics",
          "source_url": "https://doi.org/10.1542/peds.2014-1079",
          "citation_apa": "Maglione, M. A., Das, L., Raaen, L., Smith, A., Chari, R., Newberry, S., Shanman, R., Perry, T., Goetz, M. B., & Gidengil, C. (2014). Safety of vaccines used for routine immunization of US children: A systematic review. Pediatrics, 134(2), 325\u2013337. https://doi.org/10.1542/peds.2014-1079",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E38",
          "description": "An analysis of unethical research practices and methodological flaws in studies promoting a vaccine\u2013autism link, documenting fraudulent science associated with Andrew Wakefield and subsequent proponents, and highlighting the public health risks of such misinformation.",
          "source_name": "Annals of Pharmacotherapy",
          "source_url": "https://doi.org/10.1345/aph.1P470",
          "citation_apa": "Flaherty, D. K. (2011). The vaccine\u2013autism connection: A public health crisis caused by unethical medical practices and fraudulent science. Annals of Pharmacotherapy, 45(10), 1302\u20131304. https://doi.org/10.1345/aph.1P470",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "expert_testimony"
        },
        {
          "evidence_id": "E39",
          "description": "Geier & Geier (2003) analyzed the VAERS database and Department of Education data, finding dose-response curves indicating that increased cumulative mercury exposure from thimerosal-containing childhood vaccines correlated with higher rates of autism and other neurodevelopmental disorders.",
          "source_name": "Pediatric Rehabilitation",
          "source_url": "https://doi.org/10.1080/1363849031000139315",
          "citation_apa": "Geier, D. A., & Geier, M. R. (2003). An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatric Rehabilitation, 6(2), 97\u2013102. https://doi.org/10.1080/1363849031000139315",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H1"
          ],
          "refutes_hypotheses": [
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E40",
          "description": "Geier & Geier (2003) reported in Experimental Biology and Medicine that analysis of VAERS data showed a relative risk of 6.0 for autism and 6.1 for mental retardation following thimerosal-containing DTaP vaccines compared to thimerosal-free formulations.",
          "source_name": "Experimental Biology and Medicine",
          "source_url": "https://doi.org/10.1177/153537020322800603",
          "citation_apa": "Geier, M. R., & Geier, D. A. (2003). Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Experimental Biology and Medicine, 228(6), 660\u2013664. https://doi.org/10.1177/153537020322800603",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H1"
          ],
          "refutes_hypotheses": [
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E41",
          "description": "Madsen et al. (2003) analyzed Danish population-based data and observed that autism prevalence continued to rise following the removal of thimerosal from childhood vaccines in 1992, providing negative ecological evidence for a thimerosal-autism link.",
          "source_name": "Pediatrics",
          "source_url": "https://doi.org/10.1542/peds.112.3.604",
          "citation_apa": "Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., & Plesner, A. M. (2003). Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics, 112(3), 604\u2013606. https://doi.org/10.1542/peds.112.3.604",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E42",
          "description": "The Institute of Medicine Immunization Safety Review Committee (2004) concluded that the body of epidemiological evidence favors rejection of a causal relationship between both the MMR vaccine and thimerosal-containing vaccines and autism.",
          "source_name": "Institute of Medicine",
          "source_url": "https://www.ncbi.nlm.nih.gov/books/NBK25344/",
          "citation_apa": "Institute of Medicine. (2004). Immunization Safety Review: Vaccines and Autism. National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK25344/",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E43",
          "description": "A nationwide Danish cohort study of 657,461 children born between 1999 and 2010 found that receipt of the MMR vaccine was not associated with an increased risk for autism (hazard ratio for vaccinated vs. unvaccinated children not significantly different from 1).",
          "source_name": "Annals of Internal Medicine",
          "source_url": "https://www.acpjournals.org/doi/10.7326/M18-2101",
          "citation_apa": "Hviid, A., Hansen, J. V., Frisch, M., & Melbye, M. (2019). Measles, mumps, rubella vaccination and autism: A nationwide cohort study. Annals of Internal Medicine, 170(8), 513\u2013520. doi:10.7326/M18-2101",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E44",
          "description": "Ecological analysis of Danish children aged 2\u201310 diagnosed with autism from 1971 to 2000 showed no decline in autism incidence following removal of thimerosal from vaccines in 1992; autism rates continued to rise, refuting any correlation with thimerosal exposure.",
          "source_name": "Pediatrics",
          "source_url": "https://pediatrics.aappublications.org/content/112/3/604",
          "citation_apa": "Madsen, K. M., Lauritsen, M. B., Pedersen, C. B., Thorsen, P., Plesner, A. M., Andersen, P. H., & Mortensen, P. B. (2003). Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics, 112(3 Pt 1), 604\u2013606. doi:10.1542/peds.112.3.604",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E45",
          "description": "A Cochrane systematic review of MMR, MMRV, and MMR+V vaccines (up to May 2019) in over 13 million children found no evidence of increased autism risk among vaccinated vs. unvaccinated groups, while affirming vaccine effectiveness.",
          "source_name": "Cochrane Database of Systematic Reviews",
          "source_url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004407.pub3/full",
          "citation_apa": "Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2012). Vaccines for measles, mumps, rubella and varicella in children. Cochrane Database of Systematic Reviews, 2, CD004407. doi:10.1002/14651858.CD004407.pub3",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E46",
          "description": "Case-control study of 256 ASD cases and 752 matched controls in three U.S. managed care organizations found no association between prenatal or infant thimerosal (ethylmercury) exposure and risk of ASD, autistic disorder, or ASD with regression.",
          "source_name": "Pediatrics",
          "source_url": "https://pediatrics.aappublications.org/content/126/4/656",
          "citation_apa": "Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L. A., Hinrichsen, V. L., Marcy, M., Robertson, A., Eriksen, E., Lewis, E., Bernal, P., Shay, D., Davis, R. L., & DeStefano, F. (2010). Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics, 126(4), 656\u2013664. doi:10.1542/peds.2010-0309",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H1",
            "H3",
            "H4",
            "H5"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E47",
          "description": "In a reanalysis of CDC data involving African American male children, vaccination with the first MMR dose before 24 months of age was associated with a 1.73-fold increased risk of autism diagnosis, and vaccination before 36 months was associated with a 3.36-fold increased risk, compared to later vaccination timing.",
          "source_name": "Translational Neurodegeneration",
          "source_url": "https://translationalneurodegeneration.biomedcentral.com/articles/10.1186/2047-9158-3-16",
          "citation_apa": "Hooker, B. S. (2014). Measles-mumps-rubella vaccination timing and autism among young African American boys: A reanalysis of CDC data. Translational Neurodegeneration, 3, 16. https://doi.org/10.1186/2047-9158-3-16",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H5"
          ],
          "refutes_hypotheses": [
            "H2"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E48",
          "description": "A cross-national preprint analysis of 12 high-income countries found a positive association between early-life vaccine scheduling intensity (number of doses administered to infants under one year) and standardized autism incidence rates, with higher-dose countries averaging 20 doses in the first year showing elevated autism prevalence compared to countries with fewer doses.",
          "source_name": "Preprints.org",
          "source_url": "https://www.preprints.org/manuscript/202511.0675",
          "citation_apa": "Coccia, M. (2025). Infant vaccine scheduling intensity and autism incidence: A preliminary cross-national analysis to guide public health policy [Preprint]. Preprints.org. https://www.preprints.org/manuscript/202511.0675",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H5"
          ],
          "refutes_hypotheses": [
            "H2"
          ],
          "evidence_type": "quantitative"
        },
        {
          "evidence_id": "E49",
          "description": "Brookings Institution experts argue that there is no scientific evidence supporting alternative \u2018\u2018spaced-out\u2019\u2019 vaccine schedules for safety, noting that major reviews, including by the IOM, found no concerns with the current timing and that spacing delays increase risks for preventable diseases.",
          "source_name": "Brookings",
          "source_url": "https://www.brookings.edu/articles/vaccines-and-nervous-parents-why-spacing-out-the-vaccine-schedule-is-not-the-answer/",
          "citation_apa": "Brookings Institution. (2026). Vaccines and nervous parents: Why spacing out the vaccine schedule is not the answer. Brookings. https://www.brookings.edu/articles/vaccines-and-nervous-parents-why-spacing-out-the-vaccine-schedule-is-not-the-answer/",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H5"
          ],
          "evidence_type": "expert_testimony"
        },
        {
          "evidence_id": "E50",
          "description": "The Institute of Medicine\u2019s 2013 comprehensive review of the U.S. childhood immunization schedule found no evidence that the timing, number, or order of vaccines is linked to autism or other developmental disorders, though it called for research on outcomes in children with delayed schedules.",
          "source_name": "National Academies Press",
          "source_url": "https://www.nationalacademies.org/publications/13563",
          "citation_apa": "Institute of Medicine. (2013). The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. National Academies Press. https://doi.org/10.17226/13563",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H5"
          ],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E51",
          "description": "In October 2025, the CDC\u2019s Advisory Committee on Immunization Practices announced a multi-year review of the U.S. childhood vaccine schedule specifically to study timing and sequence of vaccinations, including alternative schedules used abroad and potential subgroup vulnerabilities.",
          "source_name": "Politico",
          "source_url": "https://www.politico.com/news/2025/10/09/cdc-panel-to-assess-childhood-vaccine-schedule-00600304",
          "citation_apa": "Politico. (2025, October 9). CDC panel announces plans to assess childhood vaccine schedule. Politico. https://www.politico.com/news/2025/10/09/cdc-panel-to-assess-childhood-vaccine-schedule-00600304",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H5"
          ],
          "refutes_hypotheses": [],
          "evidence_type": "institutional"
        },
        {
          "evidence_id": "E52",
          "description": "A Medical Daily report summarizing a review of nearly 1,000 children concluded there is no evidence linking the timing or scheduling of childhood vaccines to the development of autism spectrum disorder.",
          "source_name": "Medical Daily",
          "source_url": "https://www.medicaldaily.com/study-confirms-no-link-between-childhood-vaccine-schedule-and-autism-244822",
          "citation_apa": "Medical Daily. (2025). Study confirms no link between childhood vaccine schedule and autism. Medical Daily. https://www.medicaldaily.com/study-confirms-no-link-between-childhood-vaccine-schedule-and-autism-244822",
          "date_accessed": "2026-01-19",
          "supports_hypotheses": [
            "H2"
          ],
          "refutes_hypotheses": [
            "H5"
          ],
          "evidence_type": "qualitative"
        }
      ],
      "clusters": [
        {
          "cluster_id": "C1",
          "cluster_name": "Large epidemiology & meta-analyses (mostly null associations)",
          "description": "Large cohort/case-control studies and meta-analyses examining MMR, thimerosal/ethylmercury, antigen load, prenatal influenza vaccination, and temporal/timing variables; overwhelmingly report no association with ASD.",
          "evidence_ids": [
            "E1",
            "E3",
            "E4",
            "E6",
            "E9",
            "E10",
            "E14",
            "E17",
            "E18",
            "E19",
            "E20",
            "E24",
            "E26",
            "E27",
            "E28",
            "E29",
            "E30",
            "E31",
            "E32",
            "E37",
            "E41",
            "E43",
            "E44",
            "E45",
            "E46"
          ],
          "cluster_base_rate": 0.49,
          "likelihoods_by_paradigm": {
            "K0": {
              "H0": {
                "probability": 0.49,
                "justification": "Catch-all/OTHER does not specifically predict that repeated large studies will be null or positive; treat as independent of this evidence cluster \u2192 set to base rate exactly (LR=1).",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.12,
                "justification": "If vaccines directly cause autism at a detectable population level, repeated large studies/meta-analyses would more often find an association; thus observing repeated nulls is much less likely than base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.85,
                "justification": "If no causal link exists, repeated large studies should mostly report null associations; thus this null-heavy cluster is much more likely than base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.62,
                "justification": "If only a rare vulnerable subgroup exists, most population-wide studies still tend to be null; so the cluster is somewhat more likely than base rate, though not as strongly as under H2.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.58,
                "justification": "An indirect/rare immune-interaction pathway would generally yield weak/rare effects, so many null epidemiologic findings remain somewhat expected; slightly above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.55,
                "justification": "If schedule/timing effects exist only in limited circumstances, many broad studies would still be null; slightly above base rate (but less than H2), acknowledging some items in this cluster directly test timing/antigen-load.",
                "relative_to_base_rate": ""
              }
            },
            "K1": {
              "H0": {
                "probability": 0.49,
                "justification": "OTHER remains non-predictive about whether mainstream epidemiology yields null vs positive findings; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.3,
                "justification": "If one suspects residual confounding/healthy-user bias and publication/selection effects, null epidemiology is less surprising even if H1 were true; still somewhat below base rate because many independent datasets would not all wash out a real effect.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.68,
                "justification": "Null findings remain more expected under no-causation, but methodological skepticism reduces how strongly this cluster is predicted vs base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.56,
                "justification": "Rare subgroup effects still allow many null results; modestly above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.54,
                "justification": "Indirect/rare effects are compatible with many nulls; slightly above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.52,
                "justification": "Schedule effects could be hard to detect in standard observational designs; modestly above base rate but close to it under methodological skepticism.",
                "relative_to_base_rate": ""
              }
            },
            "K2": {
              "H0": {
                "probability": 0.49,
                "justification": "OTHER does not predict the direction of epidemiologic findings; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.52,
                "justification": "Under a strongly vaccine-skeptical stance (systematic bias/suppression assumed), many null studies are expected even if a true effect exists; thus slightly above base rate rather than below.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.55,
                "justification": "Even under skepticism, null findings are still somewhat expected if there is no causal link; only slightly above base rate because the paradigm treats these results as less diagnostic.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.56,
                "justification": "Rare subgroup effects plus assumed detection limitations make null-heavy literature plausible; modestly above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.55,
                "justification": "Indirect/rare pathways can evade detection; modestly above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.54,
                "justification": "If schedule effects are real but obscured, null epidemiology is not very surprising; slightly above base rate.",
                "relative_to_base_rate": ""
              }
            }
          }
        },
        {
          "cluster_id": "C2",
          "cluster_name": "Institutional consensus & authoritative reviews",
          "description": "Consensus statements and major reviews (IOM/NASEM, CDC, AAP, WHO, Brookings expert commentary, and similar) concluding no link between vaccines (including MMR, thimerosal/aluminum) and autism, and/or no schedule-timing link.",
          "evidence_ids": [
            "E2",
            "E8",
            "E11",
            "E12",
            "E13",
            "E21",
            "E25",
            "E33",
            "E34",
            "E36",
            "E42",
            "E49",
            "E50"
          ],
          "cluster_base_rate": 0.5846153846153845,
          "likelihoods_by_paradigm": {
            "K0": {
              "H0": {
                "probability": 0.58,
                "justification": "OTHER does not specifically predict whether institutions converge on 'no link' vs 'link'; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.18,
                "justification": "If vaccines truly cause autism broadly, strong cross-institutional consensus repeatedly rejecting a link is less likely than base rate (would expect more equivocation or positive findings).",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.9,
                "justification": "If no causal link exists, major institutions reviewing large bodies of evidence are very likely to converge on 'no link'; far above base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.52,
                "justification": "A rare subgroup effect could still yield broad institutional 'no population-level link' conclusions, but strong categorical messaging ('no link') is somewhat less expected than under H2; slightly below base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.5,
                "justification": "Indirect/rare immune-interaction effects would plausibly lead to more hedged institutional language; thus repeated strong 'no link' consensus is somewhat less likely than base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.48,
                "justification": "If schedule timing/sequence truly mattered, large reviews specifically of schedules would be less likely to conclude 'no evidence'; thus below base rate.",
                "relative_to_base_rate": ""
              }
            },
            "K1": {
              "H0": {
                "probability": 0.58,
                "justification": "Under skepticism about institutional incentives, consensus statements become less tied to underlying causal truth; OTHER still makes no specific prediction \u2192 set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.56,
                "justification": "If institutions are biased/motivated, 'no link' consensus could still occur even if H1 were true; thus only slightly below base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.62,
                "justification": "Even with institutional skepticism, a true no-link world still modestly increases the chance institutions say 'no link'; slightly above base rate (reduced diagnosticity).",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.58,
                "justification": "If institutions are not strongly truth-tracking, rare-subgroup hypotheses do not strongly change expected consensus outputs; approximately at base rate (treated as near-non-diagnostic here).",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.58,
                "justification": "Same rationale as H3 under this paradigm: institutional conclusions expected to be relatively insensitive to nuanced indirect pathways \u2192 set near base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.58,
                "justification": "If the schedule question is politically charged, institutions might still state reassurance regardless; treat as near base rate (low diagnosticity).",
                "relative_to_base_rate": ""
              }
            },
            "K2": {
              "H0": {
                "probability": 0.58,
                "justification": "OTHER remains non-predictive regarding institutional messaging; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.75,
                "justification": "Under a strong vaccine-skeptic paradigm (institutional capture/suppression assumed), institutional 'no link' statements are expected even if vaccines cause autism; thus above base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.55,
                "justification": "If there is truly no link, institutions may also say 'no link'; but under this paradigm such statements are not strongly truth-indicative, so only slightly below/near base rate (set slightly below to reflect expectation of institutional reassurance regardless).",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.7,
                "justification": "If only a subgroup is affected, this paradigm still expects broad institutional denial; above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.7,
                "justification": "Same as H3 under K2: denial/consensus messaging expected even with nuanced indirect harm; above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.72,
                "justification": "If schedule effects exist, K2 expects institutions to continue reassuring the public; above base rate.",
                "relative_to_base_rate": ""
              }
            }
          }
        },
        {
          "cluster_id": "C3",
          "cluster_name": "Wakefield episode: initial signal, then retraction/fraud analysis",
          "description": "The original small 1998 case series suggesting a temporal association, followed by formal retractions and analyses documenting methodological flaws/fraud and unethical practices.",
          "evidence_ids": [
            "E16",
            "E7",
            "E15",
            "E35",
            "E38"
          ],
          "cluster_base_rate": 0.33999999999999997,
          "likelihoods_by_paradigm": {
            "K0": {
              "H0": {
                "probability": 0.34,
                "justification": "OTHER does not specifically predict 'a flawed early study appears and is later retracted'; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.12,
                "justification": "If vaccines truly cause autism, one expects better-quality replicable signals rather than a landmark claim collapsing into fraud/retraction; thus this cluster is less likely than base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.65,
                "justification": "If no causal link exists, early spurious associations plus subsequent correction/retraction is relatively likely; above base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.45,
                "justification": "A rare-subgroup truth could still generate small early signals, but full fraud/retraction is less expected than under H2; modestly above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.42,
                "justification": "Indirect/rare pathway could allow early suggestive reports, but wholesale invalidation remains more consistent with 'no link'; slightly above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.4,
                "justification": "Schedule/timing effects could produce apparent temporal patterns, but this particular episode being fraudulent/retracted is not strongly predicted; slightly above base rate.",
                "relative_to_base_rate": ""
              }
            },
            "K1": {
              "H0": {
                "probability": 0.34,
                "justification": "OTHER does not predict this historical sequence; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.25,
                "justification": "If one allows for social/political contestation, retractions can occur even when some underlying risk exists; still below base rate because fraud findings weaken the expectation under H1.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.5,
                "justification": "Spurious early claims corrected later are expected under H2, but K1 reduces trust in the 'retraction implies false' inference; moderately above base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.38,
                "justification": "Rare subgroup effects plus noisy early research could still end in retraction; slightly above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.36,
                "justification": "Similar to H3 under K1; slightly above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.35,
                "justification": "Timing-only theories are not strongly illuminated by this episode; near base rate but slightly above.",
                "relative_to_base_rate": ""
              }
            },
            "K2": {
              "H0": {
                "probability": 0.34,
                "justification": "OTHER remains non-predictive about this episode; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.6,
                "justification": "Under a suppression/censorship paradigm, a prominent pro-link paper later retracted is expected if H1 is true; above base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.3,
                "justification": "If no link exists, K2 considers retraction less diagnostic (could be politicized); thus only slightly below base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.5,
                "justification": "If a subgroup effect exists, K2 still expects pushback/retraction dynamics; above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.48,
                "justification": "Indirect pathways plus perceived suppression makes this episode somewhat expected; above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.45,
                "justification": "Timing/schedule theories can align with temporal narratives that later face institutional rejection; above base rate.",
                "relative_to_base_rate": ""
              }
            }
          }
        },
        {
          "cluster_id": "C4",
          "cluster_name": "Mechanistic plausibility: immune activation models",
          "description": "Animal/translational evidence that maternal immune activation can produce autism-like phenotypes, suggesting immune-mediated pathways could influence neurodevelopment (not vaccine-specific per se).",
          "evidence_ids": [
            "E5"
          ],
          "cluster_base_rate": 0.45,
          "likelihoods_by_paradigm": {
            "K0": {
              "H0": {
                "probability": 0.45,
                "justification": "OTHER does not predict whether immune-activation animal models exist; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.55,
                "justification": "Direct vaccine-causation hypotheses often invoke immune activation/neuroinflammation mechanisms, so seeing such mechanistic models is somewhat more likely than base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.45,
                "justification": "No-link between vaccines and autism is compatible with immune activation affecting neurodevelopment via infections/other exposures; not a specific vaccine prediction \u2192 set to base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.55,
                "justification": "Subgroup vulnerability hypotheses predict that immune-related susceptibilities could matter; thus mechanistic immune-activation models are somewhat more likely than base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.75,
                "justification": "Indirect pathway via immune activation explicitly predicts mechanistic support for immune-mediated neurodevelopmental disruption; well above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.45,
                "justification": "Schedule-overload is not specifically about maternal immune activation in pregnancy; this evidence is largely orthogonal \u2192 set to base rate.",
                "relative_to_base_rate": ""
              }
            },
            "K1": {
              "H0": {
                "probability": 0.45,
                "justification": "OTHER makes no specific prediction; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.58,
                "justification": "Mechanistic plausibility evidence is treated as more suggestive under K1; somewhat above base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.45,
                "justification": "Still compatible and not specifically predicted by H2; set to base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.6,
                "justification": "Immune-vulnerability framing fits subgroup susceptibility; above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.78,
                "justification": "Immune-activation mechanism is central to H4; above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.48,
                "justification": "Schedule/timing hypotheses weakly connect via immune load ideas; slightly above base rate.",
                "relative_to_base_rate": ""
              }
            },
            "K2": {
              "H0": {
                "probability": 0.45,
                "justification": "OTHER is non-predictive; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.7,
                "justification": "Under K2, immune activation animal models are taken as strong support for vaccine causation narratives; above base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.35,
                "justification": "K2 treats immune-activation evidence as conflicting with 'no vaccine contribution'; thus below base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.68,
                "justification": "K2 expects immune susceptibility to matter for a subgroup; above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.85,
                "justification": "Immune-activation pathway is strongly aligned; well above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.55,
                "justification": "Schedule-overload claims often invoke immune mechanisms; somewhat above base rate.",
                "relative_to_base_rate": ""
              }
            }
          }
        },
        {
          "cluster_id": "C5",
          "cluster_name": "Contrarian/contested evidence & ongoing reviews (VAERS/ecological signals, preprints, subgroup/timing claims, policy noise)",
          "description": "Weaker/contested pro-link claims (VAERS-based analyses, subgroup/timing reanalyses), critiques alleging bias in null studies, cross-national schedule correlations, and signals of renewed review/uncertainty; includes some mixed media summaries around schedule.",
          "evidence_ids": [
            "E22",
            "E23",
            "E39",
            "E40",
            "E47",
            "E48",
            "E51",
            "E52"
          ],
          "cluster_base_rate": 0.325,
          "likelihoods_by_paradigm": {
            "K0": {
              "H0": {
                "probability": 0.33,
                "justification": "OTHER does not predict the appearance of a mixed set of contrarian studies/claims and review announcements; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.5,
                "justification": "If vaccines cause autism, one expects at least some positive signals and persistent controversy; thus this cluster is more likely than base rate (even if individual items are low-quality).",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.2,
                "justification": "If there is truly no causal link, some noise/false positives occur, but a concentration of pro-link claims plus policy 'reconsideration' is less likely than base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.45,
                "justification": "Rare-subgroup effects predict occasional subgroup/timing signals and ongoing debate; above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.38,
                "justification": "Indirect immune interactions could yield sporadic and hard-to-replicate signals; slightly above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.48,
                "justification": "Timing/schedule hypotheses predict schedule-intensity correlations and renewed schedule review; above base rate.",
                "relative_to_base_rate": ""
              }
            },
            "K1": {
              "H0": {
                "probability": 0.33,
                "justification": "OTHER remains non-predictive; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.55,
                "justification": "If true harm exists and mainstream methods miss it, K1 expects persistent dissent, bias critiques, and positive signals in alternative analyses; above base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.28,
                "justification": "Even with no link, motivated reasoning and p-hacking can yield contrarian signals; still below base rate but less strongly than K0.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.52,
                "justification": "Subgroup vulnerability fits occasional subgroup findings and ongoing re-analysis; above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.42,
                "justification": "Indirect pathways can be subtle and contested; modestly above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.55,
                "justification": "Schedule/timing concerns predict continued debate, ecological correlations, and institutional reviews; above base rate.",
                "relative_to_base_rate": ""
              }
            },
            "K2": {
              "H0": {
                "probability": 0.33,
                "justification": "OTHER does not predict these specific contested signals; set to base rate exactly.",
                "relative_to_base_rate": ""
              },
              "H1": {
                "probability": 0.75,
                "justification": "Under K2, contrarian signals, VAERS-based associations, subgroup timing effects, and policy reconsiderations are expected manifestations of a real causal relationship; well above base rate.",
                "relative_to_base_rate": ""
              },
              "H2": {
                "probability": 0.15,
                "justification": "If no link exists, K2 views this cluster as comparatively unlikely; below base rate.",
                "relative_to_base_rate": ""
              },
              "H3": {
                "probability": 0.65,
                "justification": "K2 expects subgroup signals and disputes if only some children are vulnerable; above base rate.",
                "relative_to_base_rate": ""
              },
              "H4": {
                "probability": 0.55,
                "justification": "K2 expects immune-mediated controversies and sporadic signals; above base rate.",
                "relative_to_base_rate": ""
              },
              "H5": {
                "probability": 0.7,
                "justification": "K2 expects schedule-intensity associations and renewed schedule scrutiny if timing matters; well above base rate.",
                "relative_to_base_rate": ""
              }
            }
          }
        }
      ],
      "total_items": 52,
      "total_clusters": 5
    },
    "posteriors_by_paradigm": {
      "K0": {
        "H0": 0.019418393559272964,
        "H1": 0.0009646095239941871,
        "H2": 0.7267455845547113,
        "H3": 0.09718440954241434,
        "H4": 0.09395199328397925,
        "H5": 0.061735009535627945
      },
      "K1": {
        "H0": 0.05783803386743788,
        "H1": 0.18901318257332653,
        "H2": 0.10705950439710862,
        "H3": 0.3104332872851061,
        "H4": 0.22332815766201541,
        "H5": 0.11232783421500543
      },
      "K2": {
        "H0": 0.02583651328987422,
        "H1": 0.22119719762938617,
        "H2": 0.025735443185726643,
        "H3": 0.31196997354544537,
        "H4": 0.23333468488392167,
        "H5": 0.18192618746564593
      }
    }
  }
}